RU2002105011A - Замещенные оксоазагетероциклические производные - Google Patents
Замещенные оксоазагетероциклические производныеInfo
- Publication number
- RU2002105011A RU2002105011A RU2002105011/04A RU2002105011A RU2002105011A RU 2002105011 A RU2002105011 A RU 2002105011A RU 2002105011/04 A RU2002105011/04 A RU 2002105011/04A RU 2002105011 A RU2002105011 A RU 2002105011A RU 2002105011 A RU2002105011 A RU 2002105011A
- Authority
- RU
- Russia
- Prior art keywords
- ylmethyl
- piperazin
- amino
- quinazolin
- sulfonyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims abstract 35
- 108010074860 Factor Xa Proteins 0.000 claims abstract 8
- 230000002401 inhibitory effect Effects 0.000 claims abstract 6
- 238000000034 method Methods 0.000 claims abstract 6
- 108010029144 Factor IIa Proteins 0.000 claims abstract 5
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract 2
- -1 methoxyethylaminomethyl Chemical group 0.000 claims 489
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 55
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 51
- 125000001072 heteroaryl group Chemical group 0.000 claims 46
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 40
- 229910052739 hydrogen Inorganic materials 0.000 claims 39
- 239000001257 hydrogen Substances 0.000 claims 39
- 150000002431 hydrogen Chemical class 0.000 claims 32
- 125000000623 heterocyclic group Chemical group 0.000 claims 29
- IWELDVXSEVIIGI-UHFFFAOYSA-N piperazin-2-one Chemical compound O=C1CNCCN1 IWELDVXSEVIIGI-UHFFFAOYSA-N 0.000 claims 29
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 claims 28
- 125000003107 substituted aryl group Chemical group 0.000 claims 28
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 27
- 229910052799 carbon Inorganic materials 0.000 claims 27
- 150000001721 carbon Chemical group 0.000 claims 27
- 229910052760 oxygen Inorganic materials 0.000 claims 24
- 229910052717 sulfur Inorganic materials 0.000 claims 24
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 22
- 125000003710 aryl alkyl group Chemical group 0.000 claims 21
- 125000004432 carbon atom Chemical group C* 0.000 claims 21
- 125000000547 substituted alkyl group Chemical group 0.000 claims 21
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 17
- 125000003118 aryl group Chemical group 0.000 claims 17
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 15
- 125000003545 alkoxy group Chemical group 0.000 claims 14
- JTHRRMFZHSDGNJ-UHFFFAOYSA-N piperazine-2,3-dione Chemical compound O=C1NCCNC1=O JTHRRMFZHSDGNJ-UHFFFAOYSA-N 0.000 claims 14
- 125000004475 heteroaralkyl group Chemical group 0.000 claims 13
- 150000001204 N-oxides Chemical class 0.000 claims 12
- 125000000217 alkyl group Chemical group 0.000 claims 12
- 125000005349 heteroarylcycloalkyl group Chemical group 0.000 claims 12
- 229940002612 prodrug Drugs 0.000 claims 12
- 239000000651 prodrug Substances 0.000 claims 12
- 150000003839 salts Chemical class 0.000 claims 12
- 125000000753 cycloalkyl group Chemical group 0.000 claims 11
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 10
- 125000002947 alkylene group Chemical group 0.000 claims 10
- 125000004350 aryl cycloalkyl group Chemical group 0.000 claims 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 10
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 9
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 9
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 9
- 125000006514 pyridin-2-ylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 claims 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 7
- 125000004450 alkenylene group Chemical group 0.000 claims 7
- 150000001408 amides Chemical class 0.000 claims 7
- 229910052736 halogen Inorganic materials 0.000 claims 7
- 150000002367 halogens Chemical class 0.000 claims 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 7
- CZAAKPFIWJXPQT-UHFFFAOYSA-N quinazolin-2-amine Chemical compound C1=CC=CC2=NC(N)=NC=C21 CZAAKPFIWJXPQT-UHFFFAOYSA-N 0.000 claims 7
- 239000012453 solvate Substances 0.000 claims 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 6
- 125000004103 aminoalkyl group Chemical group 0.000 claims 6
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 6
- ILWNJPBQNWSXDJ-FQEVSTJZSA-N (6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-propan-2-ylpiperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3C[C@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)C(C)C)=CC2=C1 ILWNJPBQNWSXDJ-FQEVSTJZSA-N 0.000 claims 5
- YRUYPOCCFXKUGQ-FQEVSTJZSA-N (6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-benzimidazol-2-yl)sulfonyl]-6-propan-2-ylpiperazin-2-one Chemical compound C1=C(Cl)C=C2NC(S(=O)(=O)N3C[C@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)C(C)C)=NC2=C1 YRUYPOCCFXKUGQ-FQEVSTJZSA-N 0.000 claims 5
- FLWBPUYNYZDVAW-KRWDZBQOSA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-(methoxymethyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3C[C@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)COC)=CC2=C1 FLWBPUYNYZDVAW-KRWDZBQOSA-N 0.000 claims 5
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims 5
- 125000004419 alkynylene group Chemical group 0.000 claims 5
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 5
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 5
- 150000004702 methyl esters Chemical class 0.000 claims 5
- 229910052757 nitrogen Inorganic materials 0.000 claims 5
- HMRPAOMZDREQHD-NRFANRHFSA-N (6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-indol-2-yl)sulfonyl]-6-propan-2-ylpiperazin-2-one Chemical compound C1=C(Cl)C=C2NC(S(=O)(=O)N3C[C@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)C(C)C)=CC2=C1 HMRPAOMZDREQHD-NRFANRHFSA-N 0.000 claims 4
- WATFFCBCBMOTJR-UHFFFAOYSA-N 2-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-6,7-dihydro-5h-1,3-benzothiazol-4-one Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC(S1)=NC2=C1CCCC2=O WATFFCBCBMOTJR-UHFFFAOYSA-N 0.000 claims 4
- 230000000694 effects Effects 0.000 claims 4
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 claims 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 4
- 125000001544 thienyl group Chemical group 0.000 claims 4
- BVJOOFWNOSOSAN-LJQANCHMSA-N (6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)sulfonyl]-6-(2-methylpropyl)piperazin-2-one Chemical compound ClC1=CC=C2NC(S(=O)(=O)N3C[C@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)CC(C)C)=CC2=C1 BVJOOFWNOSOSAN-LJQANCHMSA-N 0.000 claims 3
- UTCXKEYSWPZQAZ-QGZVFWFLSA-N (6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)sulfonyl]-6-(methoxymethyl)piperazin-2-one Chemical compound ClC1=CC=C2NC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)COC)=CC2=C1 UTCXKEYSWPZQAZ-QGZVFWFLSA-N 0.000 claims 3
- YPRAQQUUXZEJAL-NRFANRHFSA-N (6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)sulfonyl]-6-propan-2-ylpiperazin-2-one Chemical compound ClC1=CC=C2NC(S(=O)(=O)N3C[C@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)C(C)C)=CC2=C1 YPRAQQUUXZEJAL-NRFANRHFSA-N 0.000 claims 3
- CFDFZWBTINHDGA-LJQANCHMSA-N (6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-(2-methylpropyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3C[C@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)CC(C)C)=CC2=C1 CFDFZWBTINHDGA-LJQANCHMSA-N 0.000 claims 3
- WMVJTEVXTPWTIO-QGZVFWFLSA-N (6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-benzimidazol-2-yl)sulfonyl]-6-(2-methylpropyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2NC(S(=O)(=O)N3C[C@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)CC(C)C)=NC2=C1 WMVJTEVXTPWTIO-QGZVFWFLSA-N 0.000 claims 3
- RCXOEPBIGDLMFU-LJQANCHMSA-N (6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-indol-2-yl)sulfonyl]-6-(2-methylpropyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2NC(S(=O)(=O)N3C[C@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)CC(C)C)=CC2=C1 RCXOEPBIGDLMFU-LJQANCHMSA-N 0.000 claims 3
- PYKCBKZDYWPYNB-QGZVFWFLSA-N (6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-indol-2-yl)sulfonyl]-6-(methoxymethyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2NC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)COC)=CC2=C1 PYKCBKZDYWPYNB-QGZVFWFLSA-N 0.000 claims 3
- BVJOOFWNOSOSAN-IBGZPJMESA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)sulfonyl]-6-(2-methylpropyl)piperazin-2-one Chemical compound ClC1=CC=C2NC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)CC(C)C)=CC2=C1 BVJOOFWNOSOSAN-IBGZPJMESA-N 0.000 claims 3
- BNQVIOJIVRWRHU-ZDUSSCGKSA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)sulfonyl]-6-methylpiperazin-2-one Chemical compound ClC1=CC=C2NC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)C)=CC2=C1 BNQVIOJIVRWRHU-ZDUSSCGKSA-N 0.000 claims 3
- CFDFZWBTINHDGA-IBGZPJMESA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-(2-methylpropyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)CC(C)C)=CC2=C1 CFDFZWBTINHDGA-IBGZPJMESA-N 0.000 claims 3
- JDYHHQBKBCKVIJ-ZDUSSCGKSA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-methylpiperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)C)=CC2=C1 JDYHHQBKBCKVIJ-ZDUSSCGKSA-N 0.000 claims 3
- WMVJTEVXTPWTIO-KRWDZBQOSA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-benzimidazol-2-yl)sulfonyl]-6-(2-methylpropyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2NC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)CC(C)C)=NC2=C1 WMVJTEVXTPWTIO-KRWDZBQOSA-N 0.000 claims 3
- YRMPXIRUPGIBLA-LBPRGKRZSA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-benzimidazol-2-yl)sulfonyl]-6-methylpiperazin-2-one Chemical compound C1=C(Cl)C=C2NC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)C)=NC2=C1 YRMPXIRUPGIBLA-LBPRGKRZSA-N 0.000 claims 3
- RCXOEPBIGDLMFU-IBGZPJMESA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-indol-2-yl)sulfonyl]-6-(2-methylpropyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2NC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)CC(C)C)=CC2=C1 RCXOEPBIGDLMFU-IBGZPJMESA-N 0.000 claims 3
- TWKRFZFCDFYWDU-ZDUSSCGKSA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-indol-2-yl)sulfonyl]-6-methylpiperazin-2-one Chemical compound C1=C(Cl)C=C2NC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)C)=CC2=C1 TWKRFZFCDFYWDU-ZDUSSCGKSA-N 0.000 claims 3
- TUJPZNOIDMQOSD-UHFFFAOYSA-N 1-propylpiperazin-2-one Chemical compound CCCN1CCNCC1=O TUJPZNOIDMQOSD-UHFFFAOYSA-N 0.000 claims 3
- PLLLVRSRXFDRHN-UHFFFAOYSA-N 1h-pyrazole;thiophene Chemical compound C=1C=CSC=1.C=1C=NNC=1 PLLLVRSRXFDRHN-UHFFFAOYSA-N 0.000 claims 3
- XWIYUCRMWCHYJR-UHFFFAOYSA-N 1h-pyrrolo[3,2-b]pyridine Chemical compound C1=CC=C2NC=CC2=N1 XWIYUCRMWCHYJR-UHFFFAOYSA-N 0.000 claims 3
- LUEYUHCBBXWTQT-UHFFFAOYSA-N 4-phenyl-2h-triazole Chemical compound C1=NNN=C1C1=CC=CC=C1 LUEYUHCBBXWTQT-UHFFFAOYSA-N 0.000 claims 3
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 claims 3
- 125000000278 alkyl amino alkyl group Chemical group 0.000 claims 3
- IYABWNGZIDDRAK-UHFFFAOYSA-N allene Chemical group C=C=C IYABWNGZIDDRAK-UHFFFAOYSA-N 0.000 claims 3
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 claims 3
- 125000004104 aryloxy group Chemical group 0.000 claims 3
- 125000006515 benzyloxy alkyl group Chemical group 0.000 claims 3
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 claims 3
- 125000004494 ethyl ester group Chemical group 0.000 claims 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 3
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 3
- GBXYTRIBFXZUBS-UHFFFAOYSA-N oxadiazole;thiophene Chemical compound C=1C=CSC=1.C1=CON=N1 GBXYTRIBFXZUBS-UHFFFAOYSA-N 0.000 claims 3
- 230000004962 physiological condition Effects 0.000 claims 3
- KAVSMINTEBGDTI-UHFFFAOYSA-N pyridine;thiophene Chemical compound C=1C=CSC=1.C1=CC=NC=C1 KAVSMINTEBGDTI-UHFFFAOYSA-N 0.000 claims 3
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 claims 3
- 125000005415 substituted alkoxy group Chemical group 0.000 claims 3
- JEJWGAXKVFYJDN-UHFFFAOYSA-N thiadiazole;thiophene Chemical compound C=1C=CSC=1.C1=CSN=N1 JEJWGAXKVFYJDN-UHFFFAOYSA-N 0.000 claims 3
- HHNQDLUNMOECFS-UHFFFAOYSA-N thiophene;2h-triazole Chemical compound C=1C=CSC=1.C1=CNN=N1 HHNQDLUNMOECFS-UHFFFAOYSA-N 0.000 claims 3
- YSLYBMBFWXYPCG-SFHVURJKSA-N (3s)-1-[(4-amino-2-methylquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-3-propylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=C(C)N=C(N)C3=CC=2)CC1)=O)CCC)C(=O)COC1=CC=C(Cl)S1 YSLYBMBFWXYPCG-SFHVURJKSA-N 0.000 claims 2
- GMKLPHFNNRIJIU-QFIPXVFZSA-N (3s)-4-[[4-(5-chlorothiophen-2-yl)phenyl]methyl]-3-(methoxymethyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2NC3=CC=NC=C3C=2)CC1)=O)COC)CC(C=C1)=CC=C1C1=CC=C(Cl)S1 GMKLPHFNNRIJIU-QFIPXVFZSA-N 0.000 claims 2
- BNQVIOJIVRWRHU-CYBMUJFWSA-N (6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)sulfonyl]-6-methylpiperazin-2-one Chemical compound ClC1=CC=C2NC(S(=O)(=O)N3C[C@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)C)=CC2=C1 BNQVIOJIVRWRHU-CYBMUJFWSA-N 0.000 claims 2
- JDYHHQBKBCKVIJ-CYBMUJFWSA-N (6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-methylpiperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3C[C@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)C)=CC2=C1 JDYHHQBKBCKVIJ-CYBMUJFWSA-N 0.000 claims 2
- AFOIEYGNOGPVNW-OAHLLOKOSA-N (6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-benzimidazol-2-yl)sulfonyl]-6-(methoxymethyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2NC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)COC)=NC2=C1 AFOIEYGNOGPVNW-OAHLLOKOSA-N 0.000 claims 2
- YRMPXIRUPGIBLA-GFCCVEGCSA-N (6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-benzimidazol-2-yl)sulfonyl]-6-methylpiperazin-2-one Chemical compound C1=C(Cl)C=C2NC(S(=O)(=O)N3C[C@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)C)=NC2=C1 YRMPXIRUPGIBLA-GFCCVEGCSA-N 0.000 claims 2
- TWKRFZFCDFYWDU-CYBMUJFWSA-N (6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-indol-2-yl)sulfonyl]-6-methylpiperazin-2-one Chemical compound C1=C(Cl)C=C2NC(S(=O)(=O)N3C[C@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)C)=CC2=C1 TWKRFZFCDFYWDU-CYBMUJFWSA-N 0.000 claims 2
- ZXQOJMMZOHJSTB-GOSISDBHSA-N (6r)-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-(methoxymethyl)-1-[(4-pyridin-3-yl-1,3-thiazol-2-yl)methyl]piperazin-2-one Chemical compound C([C@@H]1COC)N(S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)CC(=O)N1CC(SC=1)=NC=1C1=CC=CN=C1 ZXQOJMMZOHJSTB-GOSISDBHSA-N 0.000 claims 2
- UTCXKEYSWPZQAZ-KRWDZBQOSA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)sulfonyl]-6-(methoxymethyl)piperazin-2-one Chemical compound ClC1=CC=C2NC(S(=O)(=O)N3C[C@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)COC)=CC2=C1 UTCXKEYSWPZQAZ-KRWDZBQOSA-N 0.000 claims 2
- YPRAQQUUXZEJAL-OAQYLSRUSA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)sulfonyl]-6-propan-2-ylpiperazin-2-one Chemical compound ClC1=CC=C2NC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)C(C)C)=CC2=C1 YPRAQQUUXZEJAL-OAQYLSRUSA-N 0.000 claims 2
- AFOIEYGNOGPVNW-HNNXBMFYSA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-benzimidazol-2-yl)sulfonyl]-6-(methoxymethyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2NC(S(=O)(=O)N3C[C@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)COC)=NC2=C1 AFOIEYGNOGPVNW-HNNXBMFYSA-N 0.000 claims 2
- PYKCBKZDYWPYNB-KRWDZBQOSA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-indol-2-yl)sulfonyl]-6-(methoxymethyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2NC(S(=O)(=O)N3C[C@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)COC)=CC2=C1 PYKCBKZDYWPYNB-KRWDZBQOSA-N 0.000 claims 2
- REAOXGUQRZZDRL-UHFFFAOYSA-N 1,1-diphenyl-N-(1H-pyrrolo[3,2-b]pyridin-2-yl)methanimine Chemical compound C(C1=CC=CC=C1)(C1=CC=CC=C1)=NC1=CC2=C(C=CC=N2)N1 REAOXGUQRZZDRL-UHFFFAOYSA-N 0.000 claims 2
- ULIIZNSKJMOVMX-UHFFFAOYSA-N 1,2-oxazole;thiophene Chemical compound C=1C=CSC=1.C=1C=NOC=1 ULIIZNSKJMOVMX-UHFFFAOYSA-N 0.000 claims 2
- HMVYYTRDXNKRBQ-UHFFFAOYSA-N 1,3-thiazole-4-carboxylic acid Chemical compound OC(=O)C1=CSC=N1 HMVYYTRDXNKRBQ-UHFFFAOYSA-N 0.000 claims 2
- AIASIFWCSPZBDG-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)methyl]-4a,5,6,7,8,8a-hexahydro-3h-quinoxalin-2-one Chemical compound ClC1=CC=C2NC(CN3C4CCCCC4N(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 AIASIFWCSPZBDG-UHFFFAOYSA-N 0.000 claims 2
- WWBHKWYIBPGIKU-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)methyl]-6-(methoxymethyl)piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3C(=O)CN(CC=4NC5=CC=C(Cl)C=C5C=4)CC3COC)=CC=C21 WWBHKWYIBPGIKU-UHFFFAOYSA-N 0.000 claims 2
- UXCDAPQWTIOGBJ-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)sulfonyl]piperazin-2-one Chemical compound ClC1=CC=C2NC(S(=O)(=O)N3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 UXCDAPQWTIOGBJ-UHFFFAOYSA-N 0.000 claims 2
- NPLLUEMGJMFUII-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-indol-2-yl)sulfonyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2NC(S(=O)(=O)N3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 NPLLUEMGJMFUII-UHFFFAOYSA-N 0.000 claims 2
- CVVGDDQYOHBFCF-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-4a,5,6,7,8,8a-hexahydro-3h-quinoxalin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)C2CCCCC2N1C(=O)COC1=CC=C(Cl)S1 CVVGDDQYOHBFCF-UHFFFAOYSA-N 0.000 claims 2
- MQUKKRZKNMMSLU-UHFFFAOYSA-N 1-[[4-(1-adamantyl)-1,3-thiazol-2-yl]methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound C1C(C2)CC(C3)CC2CC13C1=CSC(CN2CCN(CC2=O)S(=O)(=O)C2=CC3=CC=C(C=C3S2)Cl)=N1 MQUKKRZKNMMSLU-UHFFFAOYSA-N 0.000 claims 2
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 claims 2
- KJCIMSSFGUGTGA-UHFFFAOYSA-N 1-methylpiperazin-2-one Chemical compound CN1CCNCC1=O KJCIMSSFGUGTGA-UHFFFAOYSA-N 0.000 claims 2
- WJZYSVHAHCGIIU-INIZCTEOSA-N 2-[(2s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-oxopiperazin-2-yl]acetic acid Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3C[C@H](CC(O)=O)N(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 WJZYSVHAHCGIIU-INIZCTEOSA-N 0.000 claims 2
- AJRCIRRIQOYCEL-UHFFFAOYSA-N 2-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-4,5,6,7-tetrahydro-1,3-benzothiazole-4-carboxylic acid Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC=3SC=4CCCC(C=4N=3)C(=O)O)=CC2=C1 AJRCIRRIQOYCEL-UHFFFAOYSA-N 0.000 claims 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims 2
- WRXNJTBODVGDRY-UHFFFAOYSA-N 2-pyrrolidin-1-ylethanamine Chemical compound NCCN1CCCC1 WRXNJTBODVGDRY-UHFFFAOYSA-N 0.000 claims 2
- IIBVYWFOWLCCBZ-UHFFFAOYSA-N 3-(methoxymethyl)piperazin-2-one Chemical compound COCC1NCCNC1=O IIBVYWFOWLCCBZ-UHFFFAOYSA-N 0.000 claims 2
- CYZSVYRPFVOTIQ-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-ylmethyl)piperazin-2-one Chemical compound C1CCCC(S2)=C1N=C2CN(C(=O)C1)CCN1S(=O)(=O)C1=CC2=CC=C(Cl)C=C2S1 CYZSVYRPFVOTIQ-UHFFFAOYSA-N 0.000 claims 2
- ZHFKLZCIFNYJIP-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[(4-hydroxy-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)methyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC=3SC=4CCCC(C=4N=3)O)=CC2=C1 ZHFKLZCIFNYJIP-UHFFFAOYSA-N 0.000 claims 2
- WQAJCBIDKVJMBV-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[[1-[2-(2-hydroxyethylamino)pyrimidin-4-yl]piperidin-4-yl]methyl]piperazin-2-one Chemical compound OCCNC1=NC=CC(N2CCC(CN3C(CN(CC3)S(=O)(=O)C=3SC4=CC(Cl)=CC=C4C=3)=O)CC2)=N1 WQAJCBIDKVJMBV-UHFFFAOYSA-N 0.000 claims 2
- RFPWFEJSPIAHBG-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[[4-(4-hydroxyphenyl)-1,3-thiazol-2-yl]methyl]piperazin-2-one Chemical compound C1=CC(O)=CC=C1C1=CSC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 RFPWFEJSPIAHBG-UHFFFAOYSA-N 0.000 claims 2
- FEULSLWGSGKTLE-UHFFFAOYSA-N 4-[[4-(5-chlorothiophen-2-yl)phenyl]methyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound S1C(Cl)=CC=C1C(C=C1)=CC=C1CN1CC(=O)N(CC=2NC3=CC=NC=C3C=2)CC1 FEULSLWGSGKTLE-UHFFFAOYSA-N 0.000 claims 2
- QSNSCYSYFYORTR-UHFFFAOYSA-N 4-chloroaniline Chemical compound NC1=CC=C(Cl)C=C1 QSNSCYSYFYORTR-UHFFFAOYSA-N 0.000 claims 2
- CVICEEPAFUYBJG-UHFFFAOYSA-N 5-chloro-2,2-difluoro-1,3-benzodioxole Chemical group C1=C(Cl)C=C2OC(F)(F)OC2=C1 CVICEEPAFUYBJG-UHFFFAOYSA-N 0.000 claims 2
- 229930194542 Keto Natural products 0.000 claims 2
- KQSWGFXHXHKWHT-DQPZFDDXSA-N O=C1[C@H](COC)NCCN1CC1CCC(N2CCC(O)CC2)CC1 Chemical compound O=C1[C@H](COC)NCCN1CC1CCC(N2CCC(O)CC2)CC1 KQSWGFXHXHKWHT-DQPZFDDXSA-N 0.000 claims 2
- POUIWTKBQQJPGE-UHFFFAOYSA-N OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.O=C1CNCCN1 Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.O=C1CNCCN1 POUIWTKBQQJPGE-UHFFFAOYSA-N 0.000 claims 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 125000002252 acyl group Chemical group 0.000 claims 2
- 125000004442 acylamino group Chemical group 0.000 claims 2
- 125000004945 acylaminoalkyl group Chemical group 0.000 claims 2
- 125000005242 carbamoyl alkyl group Chemical group 0.000 claims 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 2
- QKIUAMUSENSFQQ-UHFFFAOYSA-N dimethylazanide Chemical compound C[N-]C QKIUAMUSENSFQQ-UHFFFAOYSA-N 0.000 claims 2
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 claims 2
- HECNAKPQRJGHJE-UHFFFAOYSA-N ethyl 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-benzimidazol-2-yl)sulfonyl]-6-oxopiperazine-2-carboxylate Chemical compound C1=C(Cl)C=C2NC(S(=O)(=O)N3CC(N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)C(=O)OCC)=NC2=C1 HECNAKPQRJGHJE-UHFFFAOYSA-N 0.000 claims 2
- NNVWVFCPLVDZEZ-UHFFFAOYSA-N ethyl 3-[2-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-1,3-thiazol-4-yl]-3-methylbutanoate Chemical compound CCOC(=O)CC(C)(C)C1=CSC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 NNVWVFCPLVDZEZ-UHFFFAOYSA-N 0.000 claims 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 2
- 125000000842 isoxazolyl group Chemical group 0.000 claims 2
- 125000000468 ketone group Chemical group 0.000 claims 2
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 claims 2
- 150000002923 oximes Chemical class 0.000 claims 2
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 2
- PXSNZXGXAWUECB-IBGZPJMESA-N (2S)-4-[(4-aminoquinazolin-7-yl)methyl]-N-(4-chlorophenyl)-2-(methoxymethyl)-3-oxopiperazine-1-sulfonamide Chemical compound ClC1=CC=C(C=C1)NS(=O)(=O)N1[C@H](C(N(CC1)CC1=CC=C2C(=NC=NC2=C1)N)=O)COC PXSNZXGXAWUECB-IBGZPJMESA-N 0.000 claims 1
- CDNJTKXCEJBXDV-FQEVSTJZSA-N (2S)-4-[(4-aminoquinazolin-7-yl)methyl]-N-(4-chlorophenyl)sulfonyl-3-oxo-2-propylpiperazine-1-carboxamide Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCC)C(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1 CDNJTKXCEJBXDV-FQEVSTJZSA-N 0.000 claims 1
- GNCBTIHINJEKMH-NRFANRHFSA-N (2s)-4-[(4-aminoquinazolin-7-yl)methyl]-n-(4-chlorophenyl)-2-(2-methylpropyl)-3-oxopiperazine-1-carboxamide Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CC(C)C)C(=O)NC1=CC=C(Cl)C=C1 GNCBTIHINJEKMH-NRFANRHFSA-N 0.000 claims 1
- QAIUWZPKZGZREK-FQEVSTJZSA-N (2s)-4-[(4-aminoquinazolin-7-yl)methyl]-n-(4-chlorophenyl)-2-(2-methylsulfanylethyl)-3-oxopiperazine-1-carboxamide Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCSC)C(=O)NC1=CC=C(Cl)C=C1 QAIUWZPKZGZREK-FQEVSTJZSA-N 0.000 claims 1
- NPQHGKXCYSHCLB-SFHVURJKSA-N (2s)-4-[(4-aminoquinazolin-7-yl)methyl]-n-(4-chlorophenyl)-2-(hydroxymethyl)-3-oxopiperazine-1-carboxamide Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C([C@@H]1CO)=O)CCN1C(=O)NC1=CC=C(Cl)C=C1 NPQHGKXCYSHCLB-SFHVURJKSA-N 0.000 claims 1
- JOXZRCVHHCNRBL-BTYIYWSLSA-N (2s,5s)-4-[(4-aminoquinazolin-7-yl)methyl]-n-(4-chlorophenyl)-5-methyl-3-oxo-2-propylpiperazine-1-carboxamide Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)[C@@H](C)C1)=O)CCC)C(=O)NC1=CC=C(Cl)C=C1 JOXZRCVHHCNRBL-BTYIYWSLSA-N 0.000 claims 1
- ZAFSRIZLKCJTTR-GUYCJALGSA-N (2s,5s)-4-[(4-aminoquinazolin-7-yl)methyl]-n-(5-chlorothiophen-2-yl)-5-methyl-3-oxo-2-propylpiperazine-1-carboxamide Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)[C@@H](C)C1)=O)CCC)C(=O)NC1=CC=C(Cl)S1 ZAFSRIZLKCJTTR-GUYCJALGSA-N 0.000 claims 1
- MFZMIPYYZSTAFN-QMMMGPOBSA-N (3S)-1-acetyl-3-(2-methylsulfanylethyl)piperazin-2-one Chemical compound C(C)(=O)N1C([C@@H](NCC1)CCSC)=O MFZMIPYYZSTAFN-QMMMGPOBSA-N 0.000 claims 1
- AKEHMFADNHBSPH-CYQMCQFNSA-N (3S)-1-acetyl-3-(2-methylsulfinylethyl)piperazin-2-one Chemical compound C(C)(=O)N1C([C@@H](NCC1)CCS(=O)C)=O AKEHMFADNHBSPH-CYQMCQFNSA-N 0.000 claims 1
- JFGQTKYZGYQOOG-QMMMGPOBSA-N (3S)-1-acetyl-3-(2-methylsulfonylethyl)piperazin-2-one Chemical compound C(C)(=O)N1C([C@@H](NCC1)CCS(=O)(=O)C)=O JFGQTKYZGYQOOG-QMMMGPOBSA-N 0.000 claims 1
- OJSPTVMYYWTQGD-HXOBKFHXSA-N (3S,6R)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(4-hydroxyphenyl)prop-2-enoyl]-6-methyl-3-propylpiperazin-2-one Chemical compound NC1=NC=NC2=CC(=CC=C12)CN1C([C@@H](N(C[C@H]1C)C(C=CC1=CC=C(C=C1)O)=O)CCC)=O OJSPTVMYYWTQGD-HXOBKFHXSA-N 0.000 claims 1
- MXYZABNETCECPJ-MRXNPFEDSA-N (3r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)COC1=CC=C(Cl)S1 MXYZABNETCECPJ-MRXNPFEDSA-N 0.000 claims 1
- BSHFNWHGGVUZNC-ZDUSSCGKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-3-(2-methylsulfanylethyl)piperazin-2-one Chemical compound O=C1[C@H](CCSC)NCCN1CC1=CC=C(C(N)=NC=N2)C2=C1 BSHFNWHGGVUZNC-ZDUSSCGKSA-N 0.000 claims 1
- WROGRTUJEZVSSW-DEOSSOPVSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-3-(methoxymethyl)-4-[(4-pyrimidin-4-ylphenyl)methyl]piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)CC(C=C1)=CC=C1C1=CC=NC=N1 WROGRTUJEZVSSW-DEOSSOPVSA-N 0.000 claims 1
- UKHYEXSTCVHYKA-QHCPKHFHSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-(4-imidazol-1-ylbenzoyl)-3-propylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCC)C(=O)C(C=C1)=CC=C1N1C=CN=C1 UKHYEXSTCVHYKA-QHCPKHFHSA-N 0.000 claims 1
- ZGHRZYDUEORGRH-FQEVSTJZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-(5-chloro-1-benzofuran-2-carbonyl)-3-propylpiperazin-2-one Chemical compound ClC1=CC=C2OC(C(=O)N3[C@H](C(N(CC=4C=C5N=CN=C(N)C5=CC=4)CC3)=O)CCC)=CC2=C1 ZGHRZYDUEORGRH-FQEVSTJZSA-N 0.000 claims 1
- COUFQGIBAIVOAH-FQEVSTJZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-(5-chloro-1-benzothiophene-2-carbonyl)-3-propylpiperazin-2-one Chemical compound ClC1=CC=C2SC(C(=O)N3[C@H](C(N(CC=4C=C5N=CN=C(N)C5=CC=4)CC3)=O)CCC)=CC2=C1 COUFQGIBAIVOAH-FQEVSTJZSA-N 0.000 claims 1
- SMIUMFJOKSVRHS-QFIPXVFZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-(5-hydroxy-1h-indole-2-carbonyl)-3-propylpiperazin-2-one Chemical compound OC1=CC=C2NC(C(=O)N3[C@H](C(N(CC=4C=C5N=CN=C(N)C5=CC=4)CC3)=O)CCC)=CC2=C1 SMIUMFJOKSVRHS-QFIPXVFZSA-N 0.000 claims 1
- XTUVGWUAGYHTME-FQEVSTJZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-(6-chloro-1-benzofuran-2-carbonyl)-3-(2-methylsulfanylethyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2OC(C(=O)N3[C@H](C(N(CC=4C=C5N=CN=C(N)C5=CC=4)CC3)=O)CCSC)=CC2=C1 XTUVGWUAGYHTME-FQEVSTJZSA-N 0.000 claims 1
- NJBMALYPNRWOPO-BDQAORGHSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-(6-chloro-1-benzofuran-2-carbonyl)-3-propylpiperazin-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(Cl)C=C2OC(C(=O)N3[C@H](C(N(CC=4C=C5N=CN=C(N)C5=CC=4)CC3)=O)CCC)=CC2=C1 NJBMALYPNRWOPO-BDQAORGHSA-N 0.000 claims 1
- BVJASOCDBJJIOD-FQEVSTJZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-(6-chloro-1-benzothiophene-2-carbonyl)-3-propylpiperazin-2-one Chemical compound C1=C(Cl)C=C2SC(C(=O)N3[C@H](C(N(CC=4C=C5N=CN=C(N)C5=CC=4)CC3)=O)CCC)=CC2=C1 BVJASOCDBJJIOD-FQEVSTJZSA-N 0.000 claims 1
- DAHDSWRVSTXKNO-DEOSSOPVSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-(6-hydroxynaphthalene-2-carbonyl)-3-propylpiperazin-2-one Chemical compound C1=C(O)C=CC2=CC(C(=O)N3[C@H](C(N(CC=4C=C5N=CN=C(N)C5=CC=4)CC3)=O)CCC)=CC=C21 DAHDSWRVSTXKNO-DEOSSOPVSA-N 0.000 claims 1
- NPEUCYQJPKVJKB-NRFANRHFSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(3,5-dichloro-1h-indol-2-yl)methyl]-3-(methoxymethyl)piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC4=C(C5=CC(Cl)=CC=C5N4)Cl)[C@H](C3=O)COC)=CC=C21 NPEUCYQJPKVJKB-NRFANRHFSA-N 0.000 claims 1
- UONHNCBWQSHVBK-SFHVURJKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(4-aminothieno[3,2-d]pyrimidin-6-yl)methyl]-3-(methoxymethyl)piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC=4SC5=C(N)N=CN=C5C=4)[C@H](C3=O)COC)=CC=C21 UONHNCBWQSHVBK-SFHVURJKSA-N 0.000 claims 1
- WSSZRGPFLACFOO-DEOSSOPVSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)methyl]-3-(2-methylpropyl)piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC=4NC5=CC=C(Cl)C=C5C=4)[C@H](C3=O)CC(C)C)=CC=C21 WSSZRGPFLACFOO-DEOSSOPVSA-N 0.000 claims 1
- KLDMMXIDDQEBJN-QHCPKHFHSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)methyl]-3-propylpiperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC=4NC5=CC=C(Cl)C=C5C=4)[C@H](C3=O)CCC)=CC=C21 KLDMMXIDDQEBJN-QHCPKHFHSA-N 0.000 claims 1
- SUWAPORUGXFZIZ-QHCPKHFHSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-3-methyl-1h-indol-2-yl)methyl]-3-(methoxymethyl)piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC4=C(C5=CC(Cl)=CC=C5N4)C)[C@H](C3=O)COC)=CC=C21 SUWAPORUGXFZIZ-QHCPKHFHSA-N 0.000 claims 1
- HLSPWLSRRNDJDW-QFIPXVFZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzofuran-2-yl)methyl]-3-propylpiperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC=4OC5=CC(Cl)=CC=C5C=4)[C@H](C3=O)CCC)=CC=C21 HLSPWLSRRNDJDW-QFIPXVFZSA-N 0.000 claims 1
- UFQAJBVMPZLQEE-VWLOTQADSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(7-chloroisoquinolin-3-yl)methyl]-3-(2-methylpropyl)piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC=4N=CC5=CC(Cl)=CC=C5C=4)[C@H](C3=O)CC(C)C)=CC=C21 UFQAJBVMPZLQEE-VWLOTQADSA-N 0.000 claims 1
- USJMUPNRINRCNW-KRWDZBQOSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(2-amino-1,3-thiazol-4-yl)acetyl]-3-propylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCC)C(=O)CC1=CSC(N)=N1 USJMUPNRINRCNW-KRWDZBQOSA-N 0.000 claims 1
- FMEUNAWTMBBNEO-INIZCTEOSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(3,4-dichlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)COC=1SC=C(Cl)C=1Cl FMEUNAWTMBBNEO-INIZCTEOSA-N 0.000 claims 1
- DVGRQJKJCQHZHG-KRWDZBQOSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(3,4-dichlorothiophen-2-yl)oxyacetyl]-3-propylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCC)C(=O)COC=1SC=C(Cl)C=1Cl DVGRQJKJCQHZHG-KRWDZBQOSA-N 0.000 claims 1
- PFZSMLHMQHJNJB-SFHVURJKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-3-(2-methylpropyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CC(C)C)C(=O)COC1=CC=C(Cl)S1 PFZSMLHMQHJNJB-SFHVURJKSA-N 0.000 claims 1
- SICAEVPEPWTQDS-KRWDZBQOSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-3-[(dimethylamino)methyl]piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CN(C)C)C(=O)COC1=CC=C(Cl)S1 SICAEVPEPWTQDS-KRWDZBQOSA-N 0.000 claims 1
- JBPPHJOLTWFYEQ-INIZCTEOSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(6-chloropyrazin-2-yl)oxyacetyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)COC1=CN=CC(Cl)=N1 JBPPHJOLTWFYEQ-INIZCTEOSA-N 0.000 claims 1
- JHQIOJZCXJPJHV-FQEVSTJZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(4-chlorothiophen-2-yl)prop-2-enoyl]-3-(2-methoxyethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCOC)C(=O)C=CC1=CC(Cl)=CS1 JHQIOJZCXJPJHV-FQEVSTJZSA-N 0.000 claims 1
- XDTDNCIISWGSFW-SFHVURJKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(4-chlorothiophen-2-yl)prop-2-enoyl]-3-(hydroxymethyl)piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C([C@@H]1CO)=O)CCN1C(=O)C=CC1=CC(Cl)=CS1 XDTDNCIISWGSFW-SFHVURJKSA-N 0.000 claims 1
- VUFALHGSAURHSJ-IBGZPJMESA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)prop-2-enoyl]-3-(2-methoxyethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCOC)C(=O)C=CC1=CC=C(Cl)S1 VUFALHGSAURHSJ-IBGZPJMESA-N 0.000 claims 1
- QAVKUAXCSGKMJN-FQEVSTJZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)prop-2-enoyl]-3-(2-methylpropyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CC(C)C)C(=O)C=CC1=CC=C(Cl)S1 QAVKUAXCSGKMJN-FQEVSTJZSA-N 0.000 claims 1
- JIULOLUADWLZEW-QHCPKHFHSA-N (3s)-4-[(5-chloro-1h-indol-2-yl)methyl]-3-propyl-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2NC(CN3CCN(CC=4NC5=CC=C(Cl)C=C5C=4)[C@H](C3=O)CCC)=CC2=C1 JIULOLUADWLZEW-QHCPKHFHSA-N 0.000 claims 1
- AOEYJIWBWFIEDT-IBGZPJMESA-N (3s)-4-[(7-chloroisoquinolin-3-yl)methyl]-1-[[4-(6-methoxypyridin-3-yl)phenyl]methyl]-3-methylpiperazin-2-one Chemical compound C1=NC(OC)=CC=C1C(C=C1)=CC=C1CN1C(=O)[C@H](C)N(CC=2N=CC3=CC(Cl)=CC=C3C=2)CC1 AOEYJIWBWFIEDT-IBGZPJMESA-N 0.000 claims 1
- UVKNAKBPGNSUIV-NDEPHWFRSA-N (3s)-4-[(7-chloroisoquinolin-3-yl)methyl]-1-[[4-(6-methoxypyridin-3-yl)phenyl]methyl]-3-propylpiperazin-2-one Chemical compound C=1C2=CC=C(Cl)C=C2C=NC=1CN([C@H](C1=O)CCC)CCN1CC(C=C1)=CC=C1C1=CC=C(OC)N=C1 UVKNAKBPGNSUIV-NDEPHWFRSA-N 0.000 claims 1
- MWJIZTMGTFPLEP-SFHVURJKSA-N (3s)-4-[2-(5-aminopyridin-2-yl)oxyacetyl]-1-[(4-aminoquinazolin-7-yl)methyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)COC1=CC=C(N)C=N1 MWJIZTMGTFPLEP-SFHVURJKSA-N 0.000 claims 1
- MSJUSNQDWGEVRR-SFHVURJKSA-N (3s)-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-1-[(3-imidazol-1-ylphenyl)methyl]-3-(methoxymethyl)piperazin-2-one Chemical compound C=1C=C(Cl)SC=1OCC(=O)N([C@H](C1=O)COC)CCN1CC(C=1)=CC=CC=1N1C=CN=C1 MSJUSNQDWGEVRR-SFHVURJKSA-N 0.000 claims 1
- GEQJMSSNGSOYFP-NRFANRHFSA-N (3s)-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-1-[[4-(6-methoxypyridin-3-yl)phenyl]methyl]-3-propylpiperazin-2-one Chemical compound C=1C=C(Cl)SC=1OCC(=O)N([C@H](C1=O)CCC)CCN1CC(C=C1)=CC=C1C1=CC=C(OC)N=C1 GEQJMSSNGSOYFP-NRFANRHFSA-N 0.000 claims 1
- NLSYJBWXPXMVCR-QFIPXVFZSA-N (3s)-4-[2-(5-chlorothiophen-3-yl)oxyacetyl]-1-[[4-(6-methoxypyridin-3-yl)phenyl]methyl]-3-propylpiperazin-2-one Chemical compound C=1SC(Cl)=CC=1OCC(=O)N([C@H](C1=O)CCC)CCN1CC(C=C1)=CC=C1C1=CC=C(OC)N=C1 NLSYJBWXPXMVCR-QFIPXVFZSA-N 0.000 claims 1
- VJCFOSXJHZUYOG-QFIPXVFZSA-N (3s)-4-[3-(6-amino-2-methylpyridin-3-yl)prop-2-enoyl]-1-[(4-aminoquinazolin-7-yl)methyl]-3-butylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCCC)C(=O)C=CC1=CC=C(N)N=C1C VJCFOSXJHZUYOG-QFIPXVFZSA-N 0.000 claims 1
- QVOWSXWJCKPWNF-FQEVSTJZSA-N (3s)-4-[3-(6-aminopyridin-3-yl)prop-2-enoyl]-1-[(4-aminoquinazolin-7-yl)methyl]-3-(2-methoxyethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCOC)C(=O)C=CC1=CC=C(N)N=C1 QVOWSXWJCKPWNF-FQEVSTJZSA-N 0.000 claims 1
- PLEYYMZQLBJBAY-IBGZPJMESA-N (3s)-4-[3-(6-aminopyridin-3-yl)propanoyl]-1-[(4-aminoquinazolin-7-yl)methyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)CCC1=CC=C(N)N=C1 PLEYYMZQLBJBAY-IBGZPJMESA-N 0.000 claims 1
- GJNBCDYMKMJBFL-FQEVSTJZSA-N (3s)-4-[3-(6-aminopyridin-3-yl)propanoyl]-1-[(4-aminoquinazolin-7-yl)methyl]-3-propylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCC)C(=O)CCC1=CC=C(N)N=C1 GJNBCDYMKMJBFL-FQEVSTJZSA-N 0.000 claims 1
- PBNALOSNDBJGPY-QFIPXVFZSA-N (3s)-4-[3-(6-aminopyridin-3-yl)propanoyl]-3-(methoxymethyl)-1-[[4-(6-oxo-1h-pyridin-3-yl)phenyl]methyl]piperazin-2-one Chemical compound C=1C=C(N)N=CC=1CCC(=O)N([C@H](C1=O)COC)CCN1CC(C=C1)=CC=C1C=1C=CC(=O)NC=1 PBNALOSNDBJGPY-QFIPXVFZSA-N 0.000 claims 1
- IOOMZIUMYRDFQW-QHCPKHFHSA-N (3s)-4-[[4-(2-aminopyrimidin-4-yl)phenyl]methyl]-1-[(4-aminoquinazolin-7-yl)methyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)CC(C=C1)=CC=C1C1=CC=NC(N)=N1 IOOMZIUMYRDFQW-QHCPKHFHSA-N 0.000 claims 1
- DVDFFYJYQHEPQR-DEOSSOPVSA-N (3s)-4-[[5-(3-chlorophenyl)furan-2-yl]methyl]-3-propyl-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2NC3=CC=NC=C3C=2)CC1)=O)CCC)CC(O1)=CC=C1C1=CC=CC(Cl)=C1 DVDFFYJYQHEPQR-DEOSSOPVSA-N 0.000 claims 1
- FPOUZQOUYUELER-BTYIYWSLSA-N (3s,6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-(6-chloro-1-benzofuran-2-carbonyl)-6-methyl-3-propylpiperazin-2-one Chemical compound C1=C(Cl)C=C2OC(C(=O)N3[C@H](C(N(CC=4C=C5N=CN=C(N)C5=CC=4)[C@@H](C)C3)=O)CCC)=CC2=C1 FPOUZQOUYUELER-BTYIYWSLSA-N 0.000 claims 1
- NFTHTZCCDZZDLC-KSSFIOAISA-N (3s,6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-6-methyl-3-propylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)[C@@H](C)C1)=O)CCC)C(=O)COC1=CC=C(Cl)S1 NFTHTZCCDZZDLC-KSSFIOAISA-N 0.000 claims 1
- LGCCNIXEXADPDD-LIRRHRJNSA-N (3s,6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-3-yl)oxyacetyl]-6-methyl-3-propylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)[C@@H](C)C1)=O)CCC)C(=O)COC1=CSC(Cl)=C1 LGCCNIXEXADPDD-LIRRHRJNSA-N 0.000 claims 1
- FNDOTAPZDKRLKN-NRFANRHFSA-N (6S)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-6-[(cyclopentylmethylamino)methyl]piperazin-2-one Chemical compound C([C@@H]1N(C(CN(CC2=NOC(=C2)C=2SC(Cl)=CC=2)C1)=O)CC=1C=C2N=CN=C(C2=CC=1)N)NCC1CCCC1 FNDOTAPZDKRLKN-NRFANRHFSA-N 0.000 claims 1
- FMFJKKAAUZCAFF-LJQANCHMSA-N (6S)-4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]-6-propan-2-yl-1-(1H-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound CC(C)[C@H]1CN(CC(=O)N1Cc1cc2cnccc2[nH]1)S(=O)(=O)C=Cc1ccc(Cl)s1 FMFJKKAAUZCAFF-LJQANCHMSA-N 0.000 claims 1
- LJAZIGROAHYSIW-KRWDZBQOSA-N (6S)-4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]-6-propyl-1-(1H-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound CCC[C@H]1CN(CC(=O)N1Cc1cc2cnccc2[nH]1)S(=O)(=O)C=Cc1ccc(Cl)s1 LJAZIGROAHYSIW-KRWDZBQOSA-N 0.000 claims 1
- NURCRLMTZDSNCX-OAQYLSRUSA-N (6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)methyl]-6-(2-methylpropyl)piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3C(=O)CN(CC=4NC5=CC=C(Cl)C=C5C=4)C[C@H]3CC(C)C)=CC=C21 NURCRLMTZDSNCX-OAQYLSRUSA-N 0.000 claims 1
- NLMRMVBWJCEEBL-HXUWFJFHSA-N (6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)methyl]-6-(2-methylpropyl)piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3C(=O)CN(CC=4SC5=CC(Cl)=CC=C5C=4)C[C@H]3CC(C)C)=CC=C21 NLMRMVBWJCEEBL-HXUWFJFHSA-N 0.000 claims 1
- LBFSDQWYKYNZPL-GOSISDBHSA-N (6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)methyl]-6-(methoxymethyl)piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3C(=O)CN(CC=4SC5=CC(Cl)=CC=C5C=4)C[C@@H]3COC)=CC=C21 LBFSDQWYKYNZPL-GOSISDBHSA-N 0.000 claims 1
- FLWBPUYNYZDVAW-QGZVFWFLSA-N (6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-(methoxymethyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)COC)=CC2=C1 FLWBPUYNYZDVAW-QGZVFWFLSA-N 0.000 claims 1
- QVZKFTXRRXJDLI-LJQANCHMSA-N (6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-[(propan-2-ylamino)methyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3C[C@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)CNC(C)C)=CC2=C1 QVZKFTXRRXJDLI-LJQANCHMSA-N 0.000 claims 1
- UZZJCFODHGBNAP-QGZVFWFLSA-N (6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-6-(ethoxymethyl)piperazin-2-one Chemical compound C([C@@H](N(C(=O)C1)CC=2C=C3N=CN=C(N)C3=CC=2)COCC)N1CC(=NO1)C=C1C1=CC=C(Cl)S1 UZZJCFODHGBNAP-QGZVFWFLSA-N 0.000 claims 1
- KPCCBZMZLJTXIX-MRXNPFEDSA-N (6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-6-(methoxymethyl)piperazin-2-one Chemical compound C([C@@H](N(C(=O)C1)CC=2C=C3N=CN=C(N)C3=CC=2)COC)N1CC(=NO1)C=C1C1=CC=C(Cl)S1 KPCCBZMZLJTXIX-MRXNPFEDSA-N 0.000 claims 1
- SXNOHZLZDPIQJW-GOSISDBHSA-N (6r)-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-(methoxymethyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3NC4=CC=NC=C4C=3)COC)=CC2=C1 SXNOHZLZDPIQJW-GOSISDBHSA-N 0.000 claims 1
- FHSBXUVKNRVGGG-MRXNPFEDSA-N (6r)-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-(methoxymethyl)-1-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-ylmethyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3SC=4CCCCC=4N=3)COC)=CC2=C1 FHSBXUVKNRVGGG-MRXNPFEDSA-N 0.000 claims 1
- YDHXTHMGVOOEPR-INIZCTEOSA-N (6s)-1-[(4-amino-6-chloroquinazolin-7-yl)methyl]-4-[(6-chloro-1h-benzimidazol-2-yl)sulfonyl]-6-(2-methylpropyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2NC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3C(=CC4=C(N)N=CN=C4C=3)Cl)CC(C)C)=NC2=C1 YDHXTHMGVOOEPR-INIZCTEOSA-N 0.000 claims 1
- ATAXDZRDMFWGSG-QFIPXVFZSA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)methyl]-6-(morpholin-4-ylmethyl)piperazin-2-one Chemical compound C([C@@H]1N(C(CN(CC=2NC3=CC=C(Cl)C=C3C=2)C1)=O)CC=1C=C2N=CN=C(C2=CC=1)N)N1CCOCC1 ATAXDZRDMFWGSG-QFIPXVFZSA-N 0.000 claims 1
- YPWWNMNMNRGREJ-NRFANRHFSA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)methyl]-6-[(propan-2-ylamino)methyl]piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3C(=O)CN(CC=4NC5=CC=C(Cl)C=C5C=4)C[C@@H]3CNC(C)C)=CC=C21 YPWWNMNMNRGREJ-NRFANRHFSA-N 0.000 claims 1
- YVPJSNWYWPVMPW-IBGZPJMESA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)sulfonyl]-6-[(propan-2-ylamino)methyl]piperazin-2-one Chemical compound ClC1=CC=C2NC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)CNC(C)C)=CC2=C1 YVPJSNWYWPVMPW-IBGZPJMESA-N 0.000 claims 1
- NLMRMVBWJCEEBL-FQEVSTJZSA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)methyl]-6-(2-methylpropyl)piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3C(=O)CN(CC=4SC5=CC(Cl)=CC=C5C=4)C[C@@H]3CC(C)C)=CC=C21 NLMRMVBWJCEEBL-FQEVSTJZSA-N 0.000 claims 1
- LBFSDQWYKYNZPL-SFHVURJKSA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)methyl]-6-(methoxymethyl)piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3C(=O)CN(CC=4SC5=CC(Cl)=CC=C5C=4)C[C@H]3COC)=CC=C21 LBFSDQWYKYNZPL-SFHVURJKSA-N 0.000 claims 1
- ZWBMNNLADQIJPN-FQEVSTJZSA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-(pyrrolidin-1-ylmethyl)piperazin-2-one Chemical compound C([C@@H]1N(C(CN(C1)S(=O)(=O)C=1SC2=CC(Cl)=CC=C2C=1)=O)CC=1C=C2N=CN=C(C2=CC=1)N)N1CCCC1 ZWBMNNLADQIJPN-FQEVSTJZSA-N 0.000 claims 1
- QVZKFTXRRXJDLI-IBGZPJMESA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-[(propan-2-ylamino)methyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)CNC(C)C)=CC2=C1 QVZKFTXRRXJDLI-IBGZPJMESA-N 0.000 claims 1
- ILWNJPBQNWSXDJ-HXUWFJFHSA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-propan-2-ylpiperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)C(C)C)=CC2=C1 ILWNJPBQNWSXDJ-HXUWFJFHSA-N 0.000 claims 1
- CVPJYLZMAJIUOO-SFHVURJKSA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-benzimidazol-2-yl)sulfonyl]-6-(pyrrolidin-1-ylmethyl)piperazin-2-one Chemical compound C([C@@H]1N(C(CN(C1)S(=O)(=O)C=1NC2=CC(Cl)=CC=C2N=1)=O)CC=1C=C2N=CN=C(C2=CC=1)N)N1CCCC1 CVPJYLZMAJIUOO-SFHVURJKSA-N 0.000 claims 1
- QDZMGHLCPZAESW-KRWDZBQOSA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-benzimidazol-2-yl)sulfonyl]-6-[(propan-2-ylamino)methyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2NC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)CNC(C)C)=NC2=C1 QDZMGHLCPZAESW-KRWDZBQOSA-N 0.000 claims 1
- YRUYPOCCFXKUGQ-HXUWFJFHSA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-benzimidazol-2-yl)sulfonyl]-6-propan-2-ylpiperazin-2-one Chemical compound C1=C(Cl)C=C2NC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)C(C)C)=NC2=C1 YRUYPOCCFXKUGQ-HXUWFJFHSA-N 0.000 claims 1
- HZHRIYSVCLZNNH-IBGZPJMESA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-indol-2-yl)sulfonyl]-6-[(propan-2-ylamino)methyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2NC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)CNC(C)C)=CC2=C1 HZHRIYSVCLZNNH-IBGZPJMESA-N 0.000 claims 1
- HMRPAOMZDREQHD-OAQYLSRUSA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-indol-2-yl)sulfonyl]-6-propan-2-ylpiperazin-2-one Chemical compound C1=C(Cl)C=C2NC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)C(C)C)=CC2=C1 HMRPAOMZDREQHD-OAQYLSRUSA-N 0.000 claims 1
- TWXOZYVJKKEMRE-AWEZNQCLSA-N (6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-6-(methoxymethyl)piperazin-2-one Chemical compound C([C@H](N(C(=O)C1)CC=2C=C3N=CN=C(N)C3=CC=2)COC)N1C(=O)COC1=CC=C(Cl)S1 TWXOZYVJKKEMRE-AWEZNQCLSA-N 0.000 claims 1
- ZXZIDLKPPGQBSV-HXUWFJFHSA-N (6s)-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-propan-2-yl-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3NC4=CC=NC=C4C=3)C(C)C)=CC2=C1 ZXZIDLKPPGQBSV-HXUWFJFHSA-N 0.000 claims 1
- XXQQSSMBNPADTI-IBGZPJMESA-N (6s)-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-propyl-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3NC4=CC=NC=C4C=3)CCC)=CC2=C1 XXQQSSMBNPADTI-IBGZPJMESA-N 0.000 claims 1
- KYSCQDJVEQDRIM-FQEVSTJZSA-N (6s)-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-6-(methoxymethyl)-1-[[4-(6-methoxypyridin-3-yl)phenyl]methyl]piperazin-2-one Chemical compound C([C@H]1COC)N(C(=O)COC=2SC(Cl)=CC=2)CC(=O)N1CC(C=C1)=CC=C1C1=CC=C(OC)N=C1 KYSCQDJVEQDRIM-FQEVSTJZSA-N 0.000 claims 1
- VJZHTDSMEAFUAW-SFHVURJKSA-N (6s)-6-(aminomethyl)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)methyl]piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3C(=O)CN(CC=4NC5=CC=C(Cl)C=C5C=4)C[C@@H]3CN)=CC=C21 VJZHTDSMEAFUAW-SFHVURJKSA-N 0.000 claims 1
- RHUYHJGZWVXEHW-UHFFFAOYSA-N 1,1-Dimethyhydrazine Chemical compound CN(C)N RHUYHJGZWVXEHW-UHFFFAOYSA-N 0.000 claims 1
- XBFRQODQXBMILB-UHFFFAOYSA-N 1,3-benzothiazole-4-carboxylic acid Chemical compound OC(=O)C1=CC=CC2=C1N=CS2 XBFRQODQXBMILB-UHFFFAOYSA-N 0.000 claims 1
- XLHUBROMZOAQMV-UHFFFAOYSA-N 1,4-benzosemiquinone Chemical group [O]C1=CC=C(O)C=C1 XLHUBROMZOAQMV-UHFFFAOYSA-N 0.000 claims 1
- WSNLTKPLNJAMCS-UHFFFAOYSA-N 1-(methoxymethyl)piperazin-2-one Chemical compound COCN1CCNCC1=O WSNLTKPLNJAMCS-UHFFFAOYSA-N 0.000 claims 1
- YLFUTYLBNZFDID-UHFFFAOYSA-N 1-[(4-amino-1,3-benzothiazol-2-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC=3SC=4C=CC=C(C=4N=3)N)=CC2=C1 YLFUTYLBNZFDID-UHFFFAOYSA-N 0.000 claims 1
- PAVDLYMVFNUTSN-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-(2-piperidin-3-yloxyacetyl)piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1C(=O)COC1CCCNC1 PAVDLYMVFNUTSN-UHFFFAOYSA-N 0.000 claims 1
- GXPSLBFHCWQTLO-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(2-chloroimidazo[1,2-a]pyridin-7-yl)methyl]piperazin-2-one Chemical compound C1=CN2C=C(Cl)N=C2C=C1CN(CC1=O)CCN1CC1=CC=C2C(N)=NC=NC2=C1 GXPSLBFHCWQTLO-UHFFFAOYSA-N 0.000 claims 1
- BCSJWMNINIYXSJ-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(3,5-dichloro-1h-indol-2-yl)methyl]piperazin-2-one Chemical compound N1C2=CC=C(Cl)C=C2C(Cl)=C1CN(CC1=O)CCN1CC1=CC=C2C(N)=NC=NC2=C1 BCSJWMNINIYXSJ-UHFFFAOYSA-N 0.000 claims 1
- MHSZEDPAOYJKMP-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(3-bromo-5-chloro-1h-indol-2-yl)methyl]piperazin-2-one Chemical compound N1C2=CC=C(Cl)C=C2C(Br)=C1CN(CC1=O)CCN1CC1=CC=C2C(N)=NC=NC2=C1 MHSZEDPAOYJKMP-UHFFFAOYSA-N 0.000 claims 1
- NURCRLMTZDSNCX-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)methyl]-6-(2-methylpropyl)piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3C(=O)CN(CC=4NC5=CC=C(Cl)C=C5C=4)CC3CC(C)C)=CC=C21 NURCRLMTZDSNCX-UHFFFAOYSA-N 0.000 claims 1
- IOWFCFYBWFUKJM-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-3-fluoro-1h-indol-2-yl)methyl]piperazin-2-one Chemical compound N1C2=CC=C(Cl)C=C2C(F)=C1CN(CC1=O)CCN1CC1=CC=C2C(N)=NC=NC2=C1 IOWFCFYBWFUKJM-UHFFFAOYSA-N 0.000 claims 1
- CITBBVYURFTNKL-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-3-methyl-1h-indol-2-yl)methyl]piperazin-2-one Chemical compound N1C2=CC=C(Cl)C=C2C(C)=C1CN1CC(=O)N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1 CITBBVYURFTNKL-UHFFFAOYSA-N 0.000 claims 1
- RZKZSZPNNVWFGI-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)methyl]piperazine-2,3-dione Chemical compound C1=C(Cl)C=C2SC(CN3CCN(C(C3=O)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 RZKZSZPNNVWFGI-UHFFFAOYSA-N 0.000 claims 1
- LCEFYSIYMDTACV-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-4a,5,6,7,8,8a-hexahydro-3h-quinoxalin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3C4CCCCC4N(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 LCEFYSIYMDTACV-UHFFFAOYSA-N 0.000 claims 1
- SXJRFJQQWDUBFI-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-oxopiperazine-2-carboxylic acid Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CC(N(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)C(O)=O)=CC2=C1 SXJRFJQQWDUBFI-UHFFFAOYSA-N 0.000 claims 1
- QBZNNMLBGQRFHR-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(7-chloroisoquinolin-3-yl)methyl]-4a,5,6,7,8,8a-hexahydro-3h-quinoxalin-2-one Chemical compound C1=C(Cl)C=C2C=NC(CN3C4CCCCC4N(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 QBZNNMLBGQRFHR-UHFFFAOYSA-N 0.000 claims 1
- AGOOXRJLSFZHTE-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-3,6-bis(methoxymethyl)piperazin-2-one Chemical compound COCC1C(=O)N(CC=2C=C3N=CN=C(N)C3=CC=2)C(COC)CN1C(=O)COC1=CC=C(Cl)S1 AGOOXRJLSFZHTE-UHFFFAOYSA-N 0.000 claims 1
- VWJJWDDLUUVGNL-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[[3-(5-chlorothiophen-2-yl)phenyl]methyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CC(C=1)=CC=CC=1C1=CC=C(Cl)S1 VWJJWDDLUUVGNL-UHFFFAOYSA-N 0.000 claims 1
- BAIGVSWNEZQYPE-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[[4-(5-chlorothiophen-2-yl)phenyl]methyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CC(C=C1)=CC=C1C1=CC=C(Cl)S1 BAIGVSWNEZQYPE-UHFFFAOYSA-N 0.000 claims 1
- NLKMLCWTICCFIR-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[[4-(5-chlorothiophen-2-yl)phenyl]methyl]piperazine-2,3-dione Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1=O)=O)CCN1CC(C=C1)=CC=C1C1=CC=C(Cl)S1 NLKMLCWTICCFIR-UHFFFAOYSA-N 0.000 claims 1
- YFUKVRGSOSXBNR-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]piperazine-2,3-dione Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1=O)=O)CCN1CC(=NO1)C=C1C1=CC=C(Cl)S1 YFUKVRGSOSXBNR-UHFFFAOYSA-N 0.000 claims 1
- DAOHZQMIUNRYJY-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[[5-chloro-3-(methylaminomethyl)-1h-indol-2-yl]methyl]piperazin-2-one Chemical compound N1C2=CC=C(Cl)C=C2C(CNC)=C1CN1CC(=O)N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1 DAOHZQMIUNRYJY-UHFFFAOYSA-N 0.000 claims 1
- YQTOVNOFKMYGKE-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[[5-chloro-3-(morpholin-4-ylmethyl)-1h-indol-2-yl]methyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CC=1NC2=CC=C(Cl)C=C2C=1CN1CCOCC1 YQTOVNOFKMYGKE-UHFFFAOYSA-N 0.000 claims 1
- DQAZYAIYJCTXEE-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[[5-chloro-3-(pyrrolidin-1-ylmethyl)-1h-indol-2-yl]methyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CC=1NC2=CC=C(Cl)C=C2C=1CN1CCCC1 DQAZYAIYJCTXEE-UHFFFAOYSA-N 0.000 claims 1
- XYPCPKUUOJPTJB-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[[5-chloro-3-[(dimethylamino)methyl]-1h-indol-2-yl]methyl]piperazin-2-one Chemical compound N1C2=CC=C(Cl)C=C2C(CN(C)C)=C1CN1CC(=O)N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1 XYPCPKUUOJPTJB-UHFFFAOYSA-N 0.000 claims 1
- NIEWQIUSHZNFEZ-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-6-methyl-3-propylpiperazin-2-one Chemical compound O=C1C(CCC)NCC(C)N1CC1=CC=C(C(N)=NC=N2)C2=C1 NIEWQIUSHZNFEZ-UHFFFAOYSA-N 0.000 claims 1
- WGDRCEROIJCAHS-UHFFFAOYSA-N 1-[(4-aminoquinolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)methyl]piperazine-2,3-dione Chemical compound C1=C(Cl)C=C2SC(CN3CCN(C(C3=O)=O)CC=3C=C4N=CC=C(C4=CC=3)N)=CC2=C1 WGDRCEROIJCAHS-UHFFFAOYSA-N 0.000 claims 1
- YYIOZALXURGXFL-UHFFFAOYSA-N 1-[(4-aminoquinolin-7-yl)methyl]-4-[[4-(5-chlorothiophen-2-yl)phenyl]methyl]piperazine-2,3-dione Chemical compound C=1C=C2C(N)=CC=NC2=CC=1CN(C(C1=O)=O)CCN1CC(C=C1)=CC=C1C1=CC=C(Cl)S1 YYIOZALXURGXFL-UHFFFAOYSA-N 0.000 claims 1
- ZZWIAHWEEWFXOH-UHFFFAOYSA-N 1-[(4-tert-butyl-1,3-thiazol-2-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound CC(C)(C)C1=CSC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 ZZWIAHWEEWFXOH-UHFFFAOYSA-N 0.000 claims 1
- OLYZHWCDBKQORH-UHFFFAOYSA-N 1-[(5-acetyl-4-methyl-1,3-thiazol-2-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound CC1=C(C(=O)C)SC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 OLYZHWCDBKQORH-UHFFFAOYSA-N 0.000 claims 1
- KZMYXJMZEQVWLN-UHFFFAOYSA-N 1-[4-[(4-aminoquinazolin-7-yl)methyl]-3-oxo-2-propylpiperazin-1-yl]-3-(4-hydroxyphenyl)propane-1,3-dione Chemical compound C1CN(CC=2C=C3N=CN=C(N)C3=CC=2)C(=O)C(CCC)N1C(=O)CC(=O)C1=CC=C(O)C=C1 KZMYXJMZEQVWLN-UHFFFAOYSA-N 0.000 claims 1
- ULOLZIWTTFPNIT-UHFFFAOYSA-N 1-[4-[(4-aminoquinazolin-7-yl)methyl]-3-oxo-2-propylpiperazin-1-yl]-3-(5-chlorothiophen-2-yl)-2-fluoropropane-1,3-dione Chemical compound C1CN(CC=2C=C3N=CN=C(N)C3=CC=2)C(=O)C(CCC)N1C(=O)C(F)C(=O)C1=CC=C(Cl)S1 ULOLZIWTTFPNIT-UHFFFAOYSA-N 0.000 claims 1
- QHCJJDVEXUJHGQ-UHFFFAOYSA-N 1-[4-[(4-aminoquinazolin-7-yl)methyl]-3-oxo-2-propylpiperazin-1-yl]-3-(5-chlorothiophen-2-yl)propane-1,3-dione Chemical compound C1CN(CC=2C=C3N=CN=C(N)C3=CC=2)C(=O)C(CCC)N1C(=O)CC(=O)C1=CC=C(Cl)S1 QHCJJDVEXUJHGQ-UHFFFAOYSA-N 0.000 claims 1
- ACVBXUUTOWWBEQ-UHFFFAOYSA-N 1-[4-[(4-aminoquinazolin-7-yl)methyl]-3-oxopiperazin-1-yl]-3-(5-chlorothiophen-2-yl)propane-1,3-dione Chemical compound Nc1ncnc2cc(CN3CCN(CC3=O)C(=O)CC(=O)c3ccc(Cl)s3)ccc12 ACVBXUUTOWWBEQ-UHFFFAOYSA-N 0.000 claims 1
- UZWZEXFLFCPVQT-FQEVSTJZSA-N 1-[[(2s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)methyl]-6-oxopiperazin-2-yl]methyl]-3-ethylurea Chemical compound NC1=NC=NC2=CC(CN3C(=O)CN(CC=4NC5=CC=C(Cl)C=C5C=4)C[C@@H]3CNC(=O)NCC)=CC=C21 UZWZEXFLFCPVQT-FQEVSTJZSA-N 0.000 claims 1
- SHQWVCMOTZBCKF-UHFFFAOYSA-N 1-[[4-(3-bromophenyl)-1,3-thiazol-2-yl]methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC(SC=1)=NC=1C1=CC=CC(Br)=C1 SHQWVCMOTZBCKF-UHFFFAOYSA-N 0.000 claims 1
- SMNLMIPVHBFPAP-UHFFFAOYSA-N 1-[[4-(4-bromophenyl)-1,3-thiazol-2-yl]methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC(SC=1)=NC=1C1=CC=C(Br)C=C1 SMNLMIPVHBFPAP-UHFFFAOYSA-N 0.000 claims 1
- XTIYEPGZYCNSMA-UHFFFAOYSA-N 1-[[4-(5-chlorothiophen-2-yl)phenyl]methyl]-4-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazine-2,3-dione Chemical compound S1C(Cl)=CC=C1C(C=C1)=CC=C1CN1C(=O)C(=O)N(CC=2NC3=CC=NC=C3C=2)CC1 XTIYEPGZYCNSMA-UHFFFAOYSA-N 0.000 claims 1
- BOQZXGHEWNKPED-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-4-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.S1C(Cl)=CC=C1C1=CC(CN2C(CN(CC=3NC4=CC=NC=C4C=3)CC2)=O)=NO1 BOQZXGHEWNKPED-UHFFFAOYSA-N 0.000 claims 1
- GAFJWUZJWIDXOR-UHFFFAOYSA-N 1-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-4-[(4-pyridin-4-ylphenyl)methyl]piperazine-2,3-dione Chemical compound S1C(Cl)=CC=C1C1=CC(CN2C(C(=O)N(CC=3C=CC(=CC=3)C=3C=CN=CC=3)CC2)=O)=NO1 GAFJWUZJWIDXOR-UHFFFAOYSA-N 0.000 claims 1
- JFSIBVGCGWHZAX-UHFFFAOYSA-N 1-cyano-1-cyclohexyl-2,3,3-trimethylguanidine Chemical compound CN=C(N(C#N)C1CCCCC1)N(C)C JFSIBVGCGWHZAX-UHFFFAOYSA-N 0.000 claims 1
- KHNHLBQSYWJDAJ-UHFFFAOYSA-N 1-cyano-1-cyclohexyl-2,3-dimethylguanidine Chemical compound CN=C(N(C#N)C1CCCCC1)NC KHNHLBQSYWJDAJ-UHFFFAOYSA-N 0.000 claims 1
- UVNGGQDMSIPQIW-UHFFFAOYSA-N 1-cyano-1-cyclohexyl-3-(2-hydroxyethyl)-2,3-dimethylguanidine Chemical compound CN=C(N(C#N)C1CCCCC1)N(C)CCO UVNGGQDMSIPQIW-UHFFFAOYSA-N 0.000 claims 1
- SCGAVZGSIVHGPP-UHFFFAOYSA-N 1-ethylpiperazin-2-one Chemical compound CCN1CCNCC1=O SCGAVZGSIVHGPP-UHFFFAOYSA-N 0.000 claims 1
- UQSJBENEQYVQAZ-QHCPKHFHSA-N 2-[(2s)-4-[(4-aminoquinazolin-7-yl)methyl]-1-[(7-chloroisoquinolin-3-yl)methyl]-3-oxopiperazin-2-yl]-n-methylacetamide Chemical compound NC1=NC=NC2=CC(CN3CCN(CC=4N=CC5=CC(Cl)=CC=C5C=4)[C@H](C3=O)CC(=O)NC)=CC=C21 UQSJBENEQYVQAZ-QHCPKHFHSA-N 0.000 claims 1
- HSLJRFINDOWMSL-HNNXBMFYSA-N 2-[(2s)-4-[(4-aminoquinazolin-7-yl)methyl]-2-(methoxymethyl)-3-oxopiperazin-1-yl]-n-(5-chlorothiophen-2-yl)-2-oxoacetamide Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)C(=O)NC1=CC=C(Cl)S1 HSLJRFINDOWMSL-HNNXBMFYSA-N 0.000 claims 1
- JMNXWPRLKZUFQK-UHFFFAOYSA-N 2-[2-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-1,3-thiazol-4-yl]-n,n-dimethylacetamide Chemical compound CN(C)C(=O)CC1=CSC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 JMNXWPRLKZUFQK-UHFFFAOYSA-N 0.000 claims 1
- BOQXWPQBBXCQKC-UHFFFAOYSA-N 2-[2-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-1,3-thiazol-4-yl]-n-methylacetamide Chemical compound CNC(=O)CC1=CSC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 BOQXWPQBBXCQKC-UHFFFAOYSA-N 0.000 claims 1
- UZMODBUJHXOIRP-UHFFFAOYSA-N 2-[2-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-1,3-thiazol-4-yl]-n-propan-2-ylacetamide Chemical compound CC(C)NC(=O)CC1=CSC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 UZMODBUJHXOIRP-UHFFFAOYSA-N 0.000 claims 1
- FIVQFZAPNBWHCE-UHFFFAOYSA-N 2-[2-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-1,3-thiazol-4-yl]acetic acid Chemical compound OC(=O)CC1=CSC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 FIVQFZAPNBWHCE-UHFFFAOYSA-N 0.000 claims 1
- ROVKSRJAIIXFFP-UHFFFAOYSA-N 2-[2-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-1,3-thiazol-4-yl]benzoic acid Chemical compound OC(=O)C1=CC=CC=C1C1=CSC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 ROVKSRJAIIXFFP-UHFFFAOYSA-N 0.000 claims 1
- GAGIICGXDXEGMA-CYBMUJFWSA-N 2-[[(2r)-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-(methoxymethyl)-6-oxopiperazin-1-yl]methyl]-1,3-thiazole-4-carboxylic acid Chemical compound C([C@@H]1COC)N(S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)CC(=O)N1CC1=NC(C(O)=O)=CS1 GAGIICGXDXEGMA-CYBMUJFWSA-N 0.000 claims 1
- BOXBBRWQYTWUBU-UHFFFAOYSA-N 2-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-1,3-thiazole-4-carboxylic acid Chemical compound OC(=O)C1=CSC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 BOXBBRWQYTWUBU-UHFFFAOYSA-N 0.000 claims 1
- ZXBDAQPRDFLVPL-UHFFFAOYSA-N 2-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-N-(methoxymethyl)-1,3-thiazole-4-carboxamide Chemical compound COCNC(=O)C1=CSC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 ZXBDAQPRDFLVPL-UHFFFAOYSA-N 0.000 claims 1
- XGTVLQKVDLPYTQ-UHFFFAOYSA-N 2-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-n,4-dimethyl-1,3-thiazole-5-carboxamide Chemical compound CC1=C(C(=O)NC)SC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 XGTVLQKVDLPYTQ-UHFFFAOYSA-N 0.000 claims 1
- YODRMEKVTIZSKI-UHFFFAOYSA-N 2-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-n,n,4-trimethyl-1,3-thiazole-5-carboxamide Chemical compound CC1=C(C(=O)N(C)C)SC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 YODRMEKVTIZSKI-UHFFFAOYSA-N 0.000 claims 1
- CCXQCOZBEONOFB-UHFFFAOYSA-N 2-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-n,n-dimethyl-1,3-thiazole-4-carboxamide Chemical compound CN(C)C(=O)C1=CSC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 CCXQCOZBEONOFB-UHFFFAOYSA-N 0.000 claims 1
- CVLUMURXNKJMGA-UHFFFAOYSA-N 2-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-n-methyl-1,3-thiazole-4-carboxamide Chemical compound CNC(=O)C1=CSC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 CVLUMURXNKJMGA-UHFFFAOYSA-N 0.000 claims 1
- PAOGMWFWHFSBRS-UHFFFAOYSA-N 2-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-n-methyl-n-propan-2-yl-1,3-thiazole-4-carboxamide Chemical compound CC(C)N(C)C(=O)C1=CSC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 PAOGMWFWHFSBRS-UHFFFAOYSA-N 0.000 claims 1
- XUSKVXOLHLAJOM-UHFFFAOYSA-N 2-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-n-propan-2-yl-1,3-thiazole-4-carboxamide Chemical compound CC(C)NC(=O)C1=CSC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 XUSKVXOLHLAJOM-UHFFFAOYSA-N 0.000 claims 1
- DTISDDZOXBKBAO-MRXNPFEDSA-N 2-amino-4-[[(2r)-4-[(6-chloro-1h-benzimidazol-2-yl)sulfonyl]-2-(methoxymethyl)-6-oxopiperazin-1-yl]methyl]benzonitrile Chemical compound C([C@@H]1COC)N(S(=O)(=O)C=2NC3=CC(Cl)=CC=C3N=2)CC(=O)N1CC1=CC=C(C#N)C(N)=C1 DTISDDZOXBKBAO-MRXNPFEDSA-N 0.000 claims 1
- 125000003635 2-dimethylaminoethoxy group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])O* 0.000 claims 1
- 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims 1
- UCKQCJSDSGITBE-UHFFFAOYSA-N 2-imidazol-1-ylethyl 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-oxopiperazine-2-carboxylate Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(CN(C1)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)C1C(=O)OCCN1C=CN=C1 UCKQCJSDSGITBE-UHFFFAOYSA-N 0.000 claims 1
- MUWAEBAXEVXDRT-UHFFFAOYSA-N 2-methoxypyrrolidine Chemical compound COC1CCCN1 MUWAEBAXEVXDRT-UHFFFAOYSA-N 0.000 claims 1
- FOUCGQPLTCYURZ-UHFFFAOYSA-N 2-pyrrolidin-1-ylethyl 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-3-oxopiperazine-2-carboxylate Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN1CCN(S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)C(=O)C1C(=O)OCCN1CCCC1 FOUCGQPLTCYURZ-UHFFFAOYSA-N 0.000 claims 1
- JPYREMMLJKWDCF-UHFFFAOYSA-N 3,4,4a,5,6,7,8,8a-octahydro-1h-quinoxalin-2-one Chemical compound C1CCCC2NC(=O)CNC21 JPYREMMLJKWDCF-UHFFFAOYSA-N 0.000 claims 1
- ZQVYRVKWNGGCLO-FQEVSTJZSA-N 3-[2-[(2s)-4-[(4-aminoquinazolin-7-yl)methyl]-2-(methoxymethyl)-3-oxopiperazin-1-yl]-2-oxoethyl]benzenecarboximidamide Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)CC1=CC=CC(C(N)=N)=C1 ZQVYRVKWNGGCLO-FQEVSTJZSA-N 0.000 claims 1
- YBZNPIRCJDGBSB-UHFFFAOYSA-N 3-[2-[4-[(4-aminoquinazolin-7-yl)methyl]-3-oxopiperazin-1-yl]-2-oxoethyl]benzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(CC(=O)N2CC(=O)N(CC=3C=C4N=CN=C(N)C4=CC=3)CC2)=C1 YBZNPIRCJDGBSB-UHFFFAOYSA-N 0.000 claims 1
- WOSKWBOEWXOLMW-QFIPXVFZSA-N 3-[3-[(2s)-4-[(4-aminoquinazolin-7-yl)methyl]-2-(methoxymethyl)-3-oxopiperazin-1-yl]-3-oxoprop-1-enyl]benzonitrile Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)C=CC1=CC=CC(C#N)=C1 WOSKWBOEWXOLMW-QFIPXVFZSA-N 0.000 claims 1
- LPWDETCKVJWGIK-UHFFFAOYSA-N 3-[3-[4-[(4-aminoquinazolin-7-yl)methyl]-3-oxopiperazin-1-yl]-3-oxopropyl]benzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(CCC(=O)N2CC(=O)N(CC=3C=C4N=CN=C(N)C4=CC=3)CC2)=C1 LPWDETCKVJWGIK-UHFFFAOYSA-N 0.000 claims 1
- VWEJJKNVTKJDAF-SFHVURJKSA-N 3-amino-5-[[(2s)-4-[(4-aminoquinazolin-7-yl)methyl]-2-(methoxymethyl)-3-oxopiperazin-1-yl]methyl]thiophene-2-carbonitrile Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)CC1=CC(N)=C(C#N)S1 VWEJJKNVTKJDAF-SFHVURJKSA-N 0.000 claims 1
- 125000004208 3-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C([H])C(*)=C1[H] 0.000 claims 1
- BSPUWRUTIOUGMZ-UHFFFAOYSA-N 3-methylpiperazin-2-one Chemical compound CC1NCCNC1=O BSPUWRUTIOUGMZ-UHFFFAOYSA-N 0.000 claims 1
- YGFJXYQOBMLQJE-UHFFFAOYSA-N 4-[(3-acetyl-5-chloro-1h-indol-2-yl)methyl]-1-[(4-aminoquinazolin-7-yl)methyl]piperazin-2-one Chemical compound N1C2=CC=C(Cl)C=C2C(C(=O)C)=C1CN1CC(=O)N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1 YGFJXYQOBMLQJE-UHFFFAOYSA-N 0.000 claims 1
- UGPDGFSYKBGAPB-UHFFFAOYSA-N 4-[(5-chloro-1h-indol-2-yl)sulfonyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2NC(CN3CCN(CC3=O)S(=O)(=O)C=3NC4=CC=C(C=C4C=3)Cl)=CC2=C1 UGPDGFSYKBGAPB-UHFFFAOYSA-N 0.000 claims 1
- MYKVWZWWOLURHO-UHFFFAOYSA-N 4-[(5-chloro-1h-indol-2-yl)sulfonyl]-6-(methoxymethyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound ClC1=CC=C2NC(S(=O)(=O)N3CC(N(C(=O)C3)CC=3NC4=CC=NC=C4C=3)COC)=CC2=C1 MYKVWZWWOLURHO-UHFFFAOYSA-N 0.000 claims 1
- KTOJLHCKDVXMRK-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2NC(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=CC=C(C=C4S3)Cl)=CC2=C1 KTOJLHCKDVXMRK-UHFFFAOYSA-N 0.000 claims 1
- VGXFIUFJTPNFJJ-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-(4,5,6,7-tetrahydro-[1,3]thiazolo[4,5-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1NCCC(S2)=C1N=C2CN(C(=O)C1)CCN1S(=O)(=O)C1=CC2=CC=C(Cl)C=C2S1 VGXFIUFJTPNFJJ-UHFFFAOYSA-N 0.000 claims 1
- UOHKTMNERGZJDS-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-(4,5,6,7-tetrahydro-[1,3]thiazolo[5,4-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1CNCC(S2)=C1N=C2CN(C(=O)C1)CCN1S(=O)(=O)C1=CC2=CC=C(Cl)C=C2S1 UOHKTMNERGZJDS-UHFFFAOYSA-N 0.000 claims 1
- FRKRBNXDBRYDOR-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-(piperidin-4-ylmethyl)piperazin-2-one Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC1CCNCC1 FRKRBNXDBRYDOR-UHFFFAOYSA-N 0.000 claims 1
- GEWADIJSIYYLDE-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[(1-pyrazin-2-ylpiperidin-4-yl)methyl]piperazin-2-one Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC(CC1)CCN1C1=CN=CC=N1 GEWADIJSIYYLDE-UHFFFAOYSA-N 0.000 claims 1
- UXJDQBKFDIAYEN-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[(1-pyrimidin-2-ylpiperidin-4-yl)methyl]piperazin-2-one Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC(CC1)CCN1C1=NC=CC=N1 UXJDQBKFDIAYEN-UHFFFAOYSA-N 0.000 claims 1
- RDJXFURVMDXNFX-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[(4-methyl-1,3-thiazol-2-yl)methyl]piperazin-2-one Chemical compound CC1=CSC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 RDJXFURVMDXNFX-UHFFFAOYSA-N 0.000 claims 1
- KULHGWKQZSXESJ-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[(4-phenyl-1,3-thiazol-2-yl)methyl]piperazin-2-one Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC(SC=1)=NC=1C1=CC=CC=C1 KULHGWKQZSXESJ-UHFFFAOYSA-N 0.000 claims 1
- XLJJJPSJMCFWSM-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[(4-pyridin-2-yl-1,3-thiazol-2-yl)methyl]piperazin-2-one Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC(SC=1)=NC=1C1=CC=CC=N1 XLJJJPSJMCFWSM-UHFFFAOYSA-N 0.000 claims 1
- QRYNOSKGUPZZJU-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[(4-pyridin-3-yl-1,3-thiazol-2-yl)methyl]piperazin-2-one Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC(SC=1)=NC=1C1=CC=CN=C1 QRYNOSKGUPZZJU-UHFFFAOYSA-N 0.000 claims 1
- PCEDICIDOGFPAY-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[(4-pyridin-4-yl-1,3-thiazol-2-yl)methyl]piperazin-2-one;hydrobromide Chemical compound Br.S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC(SC=1)=NC=1C1=CC=NC=C1 PCEDICIDOGFPAY-UHFFFAOYSA-N 0.000 claims 1
- RNDUUDSQVFINDP-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[(7-methyl-1h-pyrrolo[3,2-c]pyridin-2-yl)methyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC3=CC=4C=NC=C(C=4N3)C)=CC2=C1 RNDUUDSQVFINDP-UHFFFAOYSA-N 0.000 claims 1
- NRWKWQCGTWQPEO-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[[1-(2-chloropyrimidin-4-yl)piperidin-4-yl]methyl]piperazin-2-one Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC(CC1)CCN1C1=CC=NC(Cl)=N1 NRWKWQCGTWQPEO-UHFFFAOYSA-N 0.000 claims 1
- WMQMVIRAQZFLQM-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[[1-[2-(dimethylamino)pyrimidin-4-yl]piperidin-4-yl]methyl]piperazin-2-one Chemical compound CN(C)C1=NC=CC(N2CCC(CN3C(CN(CC3)S(=O)(=O)C=3SC4=CC(Cl)=CC=C4C=3)=O)CC2)=N1 WMQMVIRAQZFLQM-UHFFFAOYSA-N 0.000 claims 1
- FGOLRQBPQIURNV-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[[1-[2-[2-(2-oxoimidazolidin-1-yl)ethylamino]pyrimidin-4-yl]piperidin-4-yl]methyl]piperazin-2-one Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC(CC1)CCN1C(N=1)=CC=NC=1NCCN1CCNC1=O FGOLRQBPQIURNV-UHFFFAOYSA-N 0.000 claims 1
- AGUKJCQHGMNERN-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[[1-[2-[4-(dimethylamino)butylamino]pyrimidin-4-yl]piperidin-4-yl]methyl]piperazin-2-one Chemical compound CN(C)CCCCNC1=NC=CC(N2CCC(CN3C(CN(CC3)S(=O)(=O)C=3SC4=CC(Cl)=CC=C4C=3)=O)CC2)=N1 AGUKJCQHGMNERN-UHFFFAOYSA-N 0.000 claims 1
- BPZDIBMTNRDMAL-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[[4-(5-chlorothiophen-2-yl)-1,3-thiazol-2-yl]methyl]piperazin-2-one Chemical compound S1C(Cl)=CC=C1C1=CSC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 BPZDIBMTNRDMAL-UHFFFAOYSA-N 0.000 claims 1
- KDEWRVCDMFBEMA-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[[4-(morpholine-4-carbonyl)-1,3-thiazol-2-yl]methyl]piperazin-2-one Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC(SC=1)=NC=1C(=O)N1CCOCC1 KDEWRVCDMFBEMA-UHFFFAOYSA-N 0.000 claims 1
- TVXDGKUIFZSQKC-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[[4-(piperazine-1-carbonyl)-1,3-thiazol-2-yl]methyl]piperazin-2-one Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC(SC=1)=NC=1C(=O)N1CCNCC1 TVXDGKUIFZSQKC-UHFFFAOYSA-N 0.000 claims 1
- JOGYDPFHUFGMSS-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-(hydroxymethyl)-1-[(1-methylpyrrolo[3,2-c]pyridin-2-yl)methyl]piperazin-2-one Chemical compound N1=CC=C2N(C)C(CN3C(CN(CC3CO)S(=O)(=O)C=3SC4=CC(Cl)=CC=C4C=3)=O)=CC2=C1 JOGYDPFHUFGMSS-UHFFFAOYSA-N 0.000 claims 1
- SXNOHZLZDPIQJW-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-(methoxymethyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CC(N(C(=O)C3)CC=3NC4=CC=NC=C4C=3)COC)=CC2=C1 SXNOHZLZDPIQJW-UHFFFAOYSA-N 0.000 claims 1
- VDPVPNXNIAJSKW-UHFFFAOYSA-N 4-[(7-chloroisoquinolin-3-yl)methyl]-1-[[4-(6-methoxypyridin-3-yl)phenyl]methyl]piperazin-2-one Chemical compound C1=NC(OC)=CC=C1C(C=C1)=CC=C1CN1C(=O)CN(CC=2N=CC3=CC(Cl)=CC=C3C=2)CC1 VDPVPNXNIAJSKW-UHFFFAOYSA-N 0.000 claims 1
- BINLCYLOCVHECW-UHFFFAOYSA-N 4-[(7-chloroisoquinolin-3-yl)methyl]-1-[[4-(6-oxo-1h-pyridin-3-yl)phenyl]methyl]piperazin-2-one Chemical compound N1=CC2=CC(Cl)=CC=C2C=C1CN(CC1=O)CCN1CC(C=C1)=CC=C1C=1C=CC(=O)NC=1 BINLCYLOCVHECW-UHFFFAOYSA-N 0.000 claims 1
- AVUFQZZRFHJVRJ-FQEVSTJZSA-N 4-[[(2s)-4-[(5-chloro-1h-indol-2-yl)sulfonyl]-2-(2-methylpropyl)-6-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound C([C@@H]1CC(C)C)N(S(=O)(=O)C=2NC3=CC=C(Cl)C=C3C=2)CC(=O)N1CC1=CC=C(C(N)=N)C=C1 AVUFQZZRFHJVRJ-FQEVSTJZSA-N 0.000 claims 1
- BHTZANLPHRFPIT-FQEVSTJZSA-N 4-[[(2s)-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-(2-methylpropyl)-6-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound C([C@@H]1CC(C)C)N(S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)CC(=O)N1CC1=CC=C(C(N)=N)C=C1 BHTZANLPHRFPIT-FQEVSTJZSA-N 0.000 claims 1
- RRTRVCANLBOYRA-SFHVURJKSA-N 4-[[(2s)-4-[(6-chloro-1h-benzimidazol-2-yl)sulfonyl]-2-(2-methylpropyl)-6-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound C([C@@H]1CC(C)C)N(S(=O)(=O)C=2NC3=CC(Cl)=CC=C3N=2)CC(=O)N1CC1=CC=C(C(N)=N)C=C1 RRTRVCANLBOYRA-SFHVURJKSA-N 0.000 claims 1
- LQZRAMULIIAIEN-FQEVSTJZSA-N 4-[[(2s)-4-[(6-chloro-1h-indol-2-yl)sulfonyl]-2-(2-methylpropyl)-6-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound C([C@@H]1CC(C)C)N(S(=O)(=O)C=2NC3=CC(Cl)=CC=C3C=2)CC(=O)N1CC1=CC=C(C(N)=N)C=C1 LQZRAMULIIAIEN-FQEVSTJZSA-N 0.000 claims 1
- QSRBRJFILWMDSD-UHFFFAOYSA-N 4-[[3-(5-chlorothiophen-2-yl)-1,2-oxazol-5-yl]methyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound S1C(Cl)=CC=C1C1=NOC(CN2CC(=O)N(CC=3NC4=CC=NC=C4C=3)CC2)=C1 QSRBRJFILWMDSD-UHFFFAOYSA-N 0.000 claims 1
- AVXIZTSASMZONB-UHFFFAOYSA-N 4-[[4-(5-chlorothiophen-2-yl)phenyl]methyl]-6-(methoxymethyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1C(=O)N(CC=2NC3=CC=NC=C3C=2)C(COC)CN1CC(C=C1)=CC=C1C1=CC=C(Cl)S1 AVXIZTSASMZONB-UHFFFAOYSA-N 0.000 claims 1
- GOFCHNWBLGFEOC-UHFFFAOYSA-N 4-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]piperidine-1-carboxamide Chemical compound C1CN(C(=O)N)CCC1CN1C(=O)CN(S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)CC1 GOFCHNWBLGFEOC-UHFFFAOYSA-N 0.000 claims 1
- BKLLPBOJHRLNSI-UHFFFAOYSA-N 4-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.S1C(Cl)=CC=C1C1=CC(CN2CC(=O)N(CC=3NC4=CC=NC=C4C=3)CC2)=NO1 BKLLPBOJHRLNSI-UHFFFAOYSA-N 0.000 claims 1
- HQGAOAVNAVRNBK-UHFFFAOYSA-N 4-[[5-(5-chlorothiophen-2-yl)-1,3-oxazol-2-yl]methyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.S1C(Cl)=CC=C1C(O1)=CN=C1CN1CC(=O)N(CC=2NC3=CC=NC=C3C=2)CC1 HQGAOAVNAVRNBK-UHFFFAOYSA-N 0.000 claims 1
- OVNLEOHTDKLZQS-UHFFFAOYSA-N 4-[[5-(5-chlorothiophen-2-yl)pyridin-2-yl]methyl]-6-(methoxymethyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1C(=O)N(CC=2NC3=CC=NC=C3C=2)C(COC)CN1CC(N=C1)=CC=C1C1=CC=C(Cl)S1 OVNLEOHTDKLZQS-UHFFFAOYSA-N 0.000 claims 1
- QFJZSUYLFPXCPS-UHFFFAOYSA-N 4-[[6-(5-chlorothiophen-2-yl)pyridin-2-yl]methyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound S1C(Cl)=CC=C1C1=CC=CC(CN2CC(=O)N(CC=3NC4=CC=NC=C4C=3)CC2)=N1 QFJZSUYLFPXCPS-UHFFFAOYSA-N 0.000 claims 1
- SXXPCYXZTBJWBT-UHFFFAOYSA-N 4-[[6-(5-chlorothiophen-2-yl)pyridin-2-yl]methyl]-6-(methoxymethyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1C(=O)N(CC=2NC3=CC=NC=C3C=2)C(COC)CN1CC(N=1)=CC=CC=1C1=CC=C(Cl)S1 SXXPCYXZTBJWBT-UHFFFAOYSA-N 0.000 claims 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- PCHBMNCFKJKQPA-UHFFFAOYSA-N 5-chlorothiophen-2-amine Chemical compound NC1=CC=C(Cl)S1 PCHBMNCFKJKQPA-UHFFFAOYSA-N 0.000 claims 1
- VJZHTDSMEAFUAW-UHFFFAOYSA-N 6-(aminomethyl)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1H-indol-2-yl)methyl]piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3C(=O)CN(CC=4NC5=CC=C(Cl)C=C5C=4)CC3CN)=CC=C21 VJZHTDSMEAFUAW-UHFFFAOYSA-N 0.000 claims 1
- GSBLRHZPUXJMIR-INIZCTEOSA-N 6-[[(3s)-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-2-oxopiperazin-1-yl]methyl]-1h-quinazolin-4-one Chemical compound N1([C@H](C(N(CC=2C=C3C(=O)N=CNC3=CC=2)CC1)=O)COC)C(=O)COC1=CC=C(Cl)S1 GSBLRHZPUXJMIR-INIZCTEOSA-N 0.000 claims 1
- MVRJRFJKFXWAOE-KRWDZBQOSA-N 6-[[(3s)-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-2-oxopiperazin-1-yl]methyl]-3-methylquinazolin-4-one Chemical compound N1([C@H](C(N(CC=2C=C3C(=O)N(C)C=NC3=CC=2)CC1)=O)COC)C(=O)COC1=CC=C(Cl)S1 MVRJRFJKFXWAOE-KRWDZBQOSA-N 0.000 claims 1
- ZPKZBSBPBXZYAJ-UHFFFAOYSA-N 6-propan-2-ylpiperazin-2-one Chemical compound CC(C)C1CNCC(=O)N1 ZPKZBSBPBXZYAJ-UHFFFAOYSA-N 0.000 claims 1
- IKCFXFPVTXLNIA-DEOSSOPVSA-N 7-[[(3s)-4-[(7-chloroisoquinolin-3-yl)methyl]-3-(methoxymethyl)-2-oxopiperazin-1-yl]methyl]-2h-isoquinolin-1-one Chemical compound C1=CNC(=O)C2=CC(CN3CCN(CC=4N=CC5=CC(Cl)=CC=C5C=4)[C@H](C3=O)COC)=CC=C21 IKCFXFPVTXLNIA-DEOSSOPVSA-N 0.000 claims 1
- RWTSGLHQRCGVOS-KRWDZBQOSA-N 7-[[(3s)-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-2-oxo-3-propylpiperazin-1-yl]methyl]-1h-quinazolin-4-one Chemical compound N1([C@H](C(N(CC=2C=C3C(C(N=CN3)=O)=CC=2)CC1)=O)CCC)C(=O)COC1=CC=C(Cl)S1 RWTSGLHQRCGVOS-KRWDZBQOSA-N 0.000 claims 1
- DDNPAZNSBWHINI-IBGZPJMESA-N 7-[[(3s)-4-[3-(5-chlorothiophen-2-yl)prop-2-enoyl]-2-oxo-3-propylpiperazin-1-yl]methyl]-1h-quinazolin-4-one Chemical compound N1([C@H](C(N(CC=2C=C3C(C(N=CN3)=O)=CC=2)CC1)=O)CCC)C(=O)C=CC1=CC=C(Cl)S1 DDNPAZNSBWHINI-IBGZPJMESA-N 0.000 claims 1
- STLZNZZZHQJODP-UHFFFAOYSA-N 9-[(4-aminoquinazolin-7-yl)methyl]-6,9-diazaspiro[4.5]decan-10-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C1=O)CCNC21CCCC2 STLZNZZZHQJODP-UHFFFAOYSA-N 0.000 claims 1
- HBJIGROWZPHHNS-ZIAGYGMSSA-N C(C1=CC=CC=C1)OC(=O)N1CC(N[C@@H]2CCCC[C@@H]12)=O Chemical compound C(C1=CC=CC=C1)OC(=O)N1CC(N[C@@H]2CCCC[C@@H]12)=O HBJIGROWZPHHNS-ZIAGYGMSSA-N 0.000 claims 1
- PVEUGABVARMNQG-UHFFFAOYSA-N CC(C)NC.OC(C1=CSC(CN(CCN(C2)S(C3=CC(C=CC(Cl)=C4)=C4S3)(=O)=O)C2=O)=N1)=O Chemical compound CC(C)NC.OC(C1=CSC(CN(CCN(C2)S(C3=CC(C=CC(Cl)=C4)=C4S3)(=O)=O)C2=O)=N1)=O PVEUGABVARMNQG-UHFFFAOYSA-N 0.000 claims 1
- JOQVSXLHAPDLTF-NRFANRHFSA-N COC[C@@H]1N(CCN(Cc2ccc3c(N)ncnc3c2)C1=O)C(=O)CCc1cccc(c1)C(N)=N Chemical compound COC[C@@H]1N(CCN(Cc2ccc3c(N)ncnc3c2)C1=O)C(=O)CCc1cccc(c1)C(N)=N JOQVSXLHAPDLTF-NRFANRHFSA-N 0.000 claims 1
- CEEQCZMQIOGGFD-RXMQYKEDSA-N COC[C@H]1CN(C(O)=O)CC(=O)N1 Chemical compound COC[C@H]1CN(C(O)=O)CC(=O)N1 CEEQCZMQIOGGFD-RXMQYKEDSA-N 0.000 claims 1
- IMLXPLXPDZURHG-IBGZPJMESA-N ClC1=CC=C(C=C1)NC(=O)N1[C@H](C(N(CC1)CC1=CC=C2C(=NC=NC2=C1)N)=O)CC(NC)=O Chemical compound ClC1=CC=C(C=C1)NC(=O)N1[C@H](C(N(CC1)CC1=CC=C2C(=NC=NC2=C1)N)=O)CC(NC)=O IMLXPLXPDZURHG-IBGZPJMESA-N 0.000 claims 1
- NMLDKAIVKXRACE-HNNXBMFYSA-N ClC1=CC=C(O1)NC(=O)N1[C@H](C(N(CC1)CC1=CC=C2C(=NC=NC2=C1)N)=O)COC Chemical compound ClC1=CC=C(O1)NC(=O)N1[C@H](C(N(CC1)CC1=CC=C2C(=NC=NC2=C1)N)=O)COC NMLDKAIVKXRACE-HNNXBMFYSA-N 0.000 claims 1
- MOOGCJQSCQQNOV-UHFFFAOYSA-N ClC=1C=CC2=C(SC(=C2)S(=O)(=O)N2CC(N(CC2)CC2CCN(CC2)C2=NC(=NC=C2)CNCCCC(=O)O)=O)C1 Chemical compound ClC=1C=CC2=C(SC(=C2)S(=O)(=O)N2CC(N(CC2)CC2CCN(CC2)C2=NC(=NC=C2)CNCCCC(=O)O)=O)C1 MOOGCJQSCQQNOV-UHFFFAOYSA-N 0.000 claims 1
- SAKNAAUXGBNNMI-UHFFFAOYSA-N FC(C(=O)O)(F)F.FC(C(=O)O)(F)F.NC1=NC=NC2=CC(=CC=C12)CN1C(CN(CC1)CC1=NN=C(N1)C1=CC(=CC=C1)Cl)=O Chemical compound FC(C(=O)O)(F)F.FC(C(=O)O)(F)F.NC1=NC=NC2=CC(=CC=C12)CN1C(CN(CC1)CC1=NN=C(N1)C1=CC(=CC=C1)Cl)=O SAKNAAUXGBNNMI-UHFFFAOYSA-N 0.000 claims 1
- UKQILUDBMLHVAA-UHFFFAOYSA-N FC(C(=O)O)(F)F.FC(C(=O)O)(F)F.NC1=NC=NC2=CC(=CC=C12)CN1C(CN(CC1)CC1=NN=C(N1)C1=CC=C(C=C1)Cl)=O Chemical compound FC(C(=O)O)(F)F.FC(C(=O)O)(F)F.NC1=NC=NC2=CC(=CC=C12)CN1C(CN(CC1)CC1=NN=C(N1)C1=CC=C(C=C1)Cl)=O UKQILUDBMLHVAA-UHFFFAOYSA-N 0.000 claims 1
- PBHRUIUCEBANOM-UHFFFAOYSA-N FC(C(=O)O)(F)F.FC(C(=O)O)(F)F.NC1=NC=NC2=CC(=CC=C12)CN1C(CN(CC1)CC1=NN=C(N1)C=1SC(=CC1)Cl)=O Chemical compound FC(C(=O)O)(F)F.FC(C(=O)O)(F)F.NC1=NC=NC2=CC(=CC=C12)CN1C(CN(CC1)CC1=NN=C(N1)C=1SC(=CC1)Cl)=O PBHRUIUCEBANOM-UHFFFAOYSA-N 0.000 claims 1
- XLIBNTXIKLQWEZ-UHFFFAOYSA-N FC(C(=O)O)(F)F.NC1=NC=NC2=CC(=CC=C12)CN1C(CN(CC1)CC1=NC=C(C=C1)C=1SC(=CC1)Cl)=O Chemical compound FC(C(=O)O)(F)F.NC1=NC=NC2=CC(=CC=C12)CN1C(CN(CC1)CC1=NC=C(C=C1)C=1SC(=CC1)Cl)=O XLIBNTXIKLQWEZ-UHFFFAOYSA-N 0.000 claims 1
- DCBGTFAQYWJOSI-UHFFFAOYSA-N FC(C(=O)O)(F)F.NC1=NC=NC2=CC(=CC=C12)CN1C(CN(CC1)CC=1C=CC(=NC1)C=1SC(=CC1)Cl)=O Chemical compound FC(C(=O)O)(F)F.NC1=NC=NC2=CC(=CC=C12)CN1C(CN(CC1)CC=1C=CC(=NC1)C=1SC(=CC1)Cl)=O DCBGTFAQYWJOSI-UHFFFAOYSA-N 0.000 claims 1
- CVGTXYFZQJFGBR-UHFFFAOYSA-N N-(methoxymethyl)-1,3-thiazole-4-carboxamide Chemical compound S1C=NC(=C1)C(=O)NCOC CVGTXYFZQJFGBR-UHFFFAOYSA-N 0.000 claims 1
- QOWFELCEAKZXRS-SFHVURJKSA-N NC(=O)C[C@@H]1N(CCN(Cc2ccc3c(N)ncnc3c2)C1=O)C(=O)Nc1ccc(Cl)cc1 Chemical compound NC(=O)C[C@@H]1N(CCN(Cc2ccc3c(N)ncnc3c2)C1=O)C(=O)Nc1ccc(Cl)cc1 QOWFELCEAKZXRS-SFHVURJKSA-N 0.000 claims 1
- BJIAQSHXZLZXIT-NRFANRHFSA-N NC1=CC=C(C=N1)C=CC(=O)N1[C@H](C(N(CC1)CC1=CC=C2C(=NC=NC2=C1)N)=O)CC(C)C Chemical compound NC1=CC=C(C=N1)C=CC(=O)N1[C@H](C(N(CC1)CC1=CC=C2C(=NC=NC2=C1)N)=O)CC(C)C BJIAQSHXZLZXIT-NRFANRHFSA-N 0.000 claims 1
- VJRLUPCFFUYTIV-IBGZPJMESA-N NC1=NC=NC2=CC(=CC=C12)CN1C([C@@H](N(CC1)C(=O)C=1C=C(C(=N)N)C=CC1)COC)=O Chemical compound NC1=NC=NC2=CC(=CC=C12)CN1C([C@@H](N(CC1)C(=O)C=1C=C(C(=N)N)C=CC1)COC)=O VJRLUPCFFUYTIV-IBGZPJMESA-N 0.000 claims 1
- KNXBIADNKGGFFL-KRWDZBQOSA-N NC1=NC=NC2=CC(=CC=C12)CN1C([C@@H](N(CC1)C(COC1=NC(=CN=C1)Cl)=O)CCC)=O Chemical compound NC1=NC=NC2=CC(=CC=C12)CN1C([C@@H](N(CC1)C(COC1=NC(=CN=C1)Cl)=O)CCC)=O KNXBIADNKGGFFL-KRWDZBQOSA-N 0.000 claims 1
- GDXNCMHLQYCCCC-IBGZPJMESA-N OC1=CC=C(C=C1)NC(=O)N1[C@H](C(N(CC1)CC1=CC=C2C(=NC=NC2=C1)N)=O)COC Chemical compound OC1=CC=C(C=C1)NC(=O)N1[C@H](C(N(CC1)CC1=CC=C2C(=NC=NC2=C1)N)=O)COC GDXNCMHLQYCCCC-IBGZPJMESA-N 0.000 claims 1
- 244000019194 Sorbus aucuparia Species 0.000 claims 1
- LMERQYRIZQPDGG-SFHVURJKSA-N [(2s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)methyl]-6-oxopiperazin-2-yl]methylurea Chemical compound NC1=NC=NC2=CC(CN3C(=O)CN(CC=4NC5=CC=C(Cl)C=C5C=4)C[C@@H]3CNC(=O)N)=CC=C21 LMERQYRIZQPDGG-SFHVURJKSA-N 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 125000005354 acylalkyl group Chemical group 0.000 claims 1
- 125000004687 alkyl sulfinyl alkyl group Chemical group 0.000 claims 1
- 125000004688 alkyl sulfonyl alkyl group Chemical group 0.000 claims 1
- 125000006350 alkyl thio alkyl group Chemical group 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims 1
- PXXJHWLDUBFPOL-UHFFFAOYSA-N benzamidine Chemical compound NC(=N)C1=CC=CC=C1 PXXJHWLDUBFPOL-UHFFFAOYSA-N 0.000 claims 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- SNXRMIWZSPUNPZ-UHFFFAOYSA-N benzyl 2-cyclopentyl-3-oxopiperazine-1-carboxylate Chemical compound C1CNC(=O)C(C2CCCC2)N1C(=O)OCC1=CC=CC=C1 SNXRMIWZSPUNPZ-UHFFFAOYSA-N 0.000 claims 1
- 125000005569 butenylene group Chemical group 0.000 claims 1
- 125000004181 carboxyalkyl group Chemical group 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000006310 cycloalkyl amino group Chemical group 0.000 claims 1
- KSMVZQYAVGTKIV-UHFFFAOYSA-N decanal Chemical compound CCCCCCCCCC=O KSMVZQYAVGTKIV-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- XBCAPAHXPBVJNE-OAHLLOKOSA-N ethyl 2-[[(2r)-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-(methoxymethyl)-6-oxopiperazin-1-yl]methyl]-1,3-thiazole-4-carboxylate Chemical compound CCOC(=O)C1=CSC(CN2C(CN(C[C@@H]2COC)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 XBCAPAHXPBVJNE-OAHLLOKOSA-N 0.000 claims 1
- ZCJNLMJJRJPFNM-UHFFFAOYSA-N ethyl 2-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-1,3-thiazole-4-carboxylate Chemical compound CCOC(=O)C1=CSC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 ZCJNLMJJRJPFNM-UHFFFAOYSA-N 0.000 claims 1
- BWLMQHXPIWJDBC-UHFFFAOYSA-N ethyl 2-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-4,5,6,7-tetrahydro-1,3-benzothiazole-4-carboxylate Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC=3SC=4CCCC(C=4N=3)C(=O)OCC)=CC2=C1 BWLMQHXPIWJDBC-UHFFFAOYSA-N 0.000 claims 1
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 claims 1
- 125000004404 heteroalkyl group Chemical group 0.000 claims 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims 1
- VQRXMIGFCMMVRN-UHFFFAOYSA-N methyl 1-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-5-oxo-4-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazine-2-carboxylate Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CC(=O)N(CC=4NC5=CC=NC=C5C=4)CC3C(=O)OC)=CC2=C1 VQRXMIGFCMMVRN-UHFFFAOYSA-N 0.000 claims 1
- RVKWHVYFQDHCKM-INIZCTEOSA-N methyl 2-[(2s)-4-[(4-aminoquinazolin-7-yl)methyl]-1-[2-(5-chlorothiophen-2-yl)oxyacetyl]-3-oxopiperazin-2-yl]acetate Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CC(=O)OC)C(=O)COC1=CC=C(Cl)S1 RVKWHVYFQDHCKM-INIZCTEOSA-N 0.000 claims 1
- KWZXRUBDWWPWEL-UHFFFAOYSA-N methyl 2-[2-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-1,3-thiazol-4-yl]acetate Chemical compound COC(=O)CC1=CSC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 KWZXRUBDWWPWEL-UHFFFAOYSA-N 0.000 claims 1
- ZKURWMUCYYKGGS-UHFFFAOYSA-N methyl 2-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-4-methyl-1,3-thiazole-5-carboxylate Chemical compound CC1=C(C(=O)OC)SC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=N1 ZKURWMUCYYKGGS-UHFFFAOYSA-N 0.000 claims 1
- VGZCRYWFMYLTGA-UHFFFAOYSA-N methyl 4-[(5-chloro-1h-indol-2-yl)sulfonyl]-1-[[1-[2-(dimethylamino)pyrimidin-4-yl]piperidin-4-yl]methyl]-6-oxopiperazine-2-carboxylate Chemical class COC(=O)C1CN(S(=O)(=O)C=2NC3=CC=C(Cl)C=C3C=2)CC(=O)N1CC(CC1)CCN1C1=CC=NC(N(C)C)=N1 VGZCRYWFMYLTGA-UHFFFAOYSA-N 0.000 claims 1
- DAIFKXIICYHYRG-UHFFFAOYSA-N methyl 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-oxo-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazine-2-carboxylate Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CC(N(C(=O)C3)CC=3NC4=CC=NC=C4C=3)C(=O)OC)=CC2=C1 DAIFKXIICYHYRG-UHFFFAOYSA-N 0.000 claims 1
- NHJSPUSLYFOJGD-UHFFFAOYSA-N methyl 4-[(6-chloro-1h-benzimidazol-2-yl)sulfonyl]-1-[[1-[2-(dimethylamino)pyrimidin-4-yl]piperidin-4-yl]methyl]-6-oxopiperazine-2-carboxylate Chemical class COC(=O)C1CN(S(=O)(=O)C=2NC3=CC(Cl)=CC=C3N=2)CC(=O)N1CC(CC1)CCN1C1=CC=NC(N(C)C)=N1 NHJSPUSLYFOJGD-UHFFFAOYSA-N 0.000 claims 1
- GUDJJBCDIANKFK-UHFFFAOYSA-N methyl 4-[(6-chloro-1h-indol-2-yl)sulfonyl]-1-[[1-[2-(dimethylamino)pyrimidin-4-yl]piperidin-4-yl]methyl]-6-oxopiperazine-2-carboxylate Chemical class COC(=O)C1CN(S(=O)(=O)C=2NC3=CC(Cl)=CC=C3C=2)CC(=O)N1CC(CC1)CCN1C1=CC=NC(N(C)C)=N1 GUDJJBCDIANKFK-UHFFFAOYSA-N 0.000 claims 1
- BBKNMQLOVMQZRO-UHFFFAOYSA-N methyl 6-chloro-1-benzofuran-2-carboxylate Chemical compound C1=C(Cl)C=C2OC(C(=O)OC)=CC2=C1 BBKNMQLOVMQZRO-UHFFFAOYSA-N 0.000 claims 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims 1
- NEGMYNFLPUIGMK-DEOSSOPVSA-N n-[5-[3-[(2s)-4-[(4-aminoquinazolin-7-yl)methyl]-2-butyl-3-oxopiperazin-1-yl]-3-oxoprop-1-enyl]-6-methylpyridin-2-yl]acetamide Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCCC)C(=O)C=CC1=CC=C(NC(C)=O)N=C1C NEGMYNFLPUIGMK-DEOSSOPVSA-N 0.000 claims 1
- GGDKZTYZCFUSEW-QHCPKHFHSA-N n-[5-[3-[(2s)-4-[(4-aminoquinazolin-7-yl)methyl]-2-butyl-3-oxopiperazin-1-yl]-3-oxoprop-1-enyl]pyridin-2-yl]acetamide Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCCC)C(=O)C=CC1=CC=C(NC(C)=O)N=C1 GGDKZTYZCFUSEW-QHCPKHFHSA-N 0.000 claims 1
- CNXJIWFSMUUYLH-NRFANRHFSA-N n-[[(2r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methyl]-6-oxopiperazin-2-yl]methyl]-n-(2-propan-2-yloxyethyl)methanimidamide Chemical compound C([C@@H](N(C(=O)C1)CC=2C=C3N=CN=C(N)C3=CC=2)CN(CCOC(C)C)C=N)N1CC(=NO1)C=C1C1=CC=C(Cl)S1 CNXJIWFSMUUYLH-NRFANRHFSA-N 0.000 claims 1
- OVABIGPDKNRCDX-IBGZPJMESA-N n-[[(2s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)methyl]-6-oxopiperazin-2-yl]methyl]formamide Chemical compound ClC1=CC=C2NC(CN3C[C@H](CNC=O)N(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 OVABIGPDKNRCDX-IBGZPJMESA-N 0.000 claims 1
- BVIVTOCVZHBRSJ-LJQANCHMSA-N n-[[(2s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)methyl]-6-oxopiperazin-2-yl]methyl]methanesulfonamide Chemical compound NC1=NC=NC2=CC(CN3C(=O)CN(CC=4NC5=CC=C(Cl)C=C5C=4)C[C@H]3CNS(=O)(=O)C)=CC=C21 BVIVTOCVZHBRSJ-LJQANCHMSA-N 0.000 claims 1
- ZMUADARPXLFDHP-UHFFFAOYSA-N nitrocarbamic acid Chemical compound OC(=O)N[N+]([O-])=O ZMUADARPXLFDHP-UHFFFAOYSA-N 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 230000035790 physiological processes and functions Effects 0.000 claims 1
- VPQAQEOATKTJSK-UHFFFAOYSA-N piperidine;pyrimidine Chemical compound C1CCNCC1.C1=CN=CN=C1 VPQAQEOATKTJSK-UHFFFAOYSA-N 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- DRYRBWIFRVMRPV-UHFFFAOYSA-N quinazolin-4-amine Chemical compound C1=CC=C2C(N)=NC=NC2=C1 DRYRBWIFRVMRPV-UHFFFAOYSA-N 0.000 claims 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 claims 1
- 235000006414 serbal de cazadores Nutrition 0.000 claims 1
- 239000010802 sludge Substances 0.000 claims 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 1
- JXJFAWJZUYQMJC-IBGZPJMESA-N tert-butyl 2-[(2s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-oxopiperazin-2-yl]acetate Chemical class C1=C(Cl)C=C2SC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)CC(=O)OC(C)(C)C)=CC2=C1 JXJFAWJZUYQMJC-IBGZPJMESA-N 0.000 claims 1
- REBNTWUPTFVVKF-UHFFFAOYSA-N tert-butyl 3-(5-chlorothiophen-2-yl)-3-oxopropanoate Chemical compound CC(C)(C)OC(=O)CC(=O)C1=CC=C(Cl)S1 REBNTWUPTFVVKF-UHFFFAOYSA-N 0.000 claims 1
- ILUBQLROFBISHX-UHFFFAOYSA-N tert-butyl 5-chloro-2-chlorosulfonylindole-1-carboxylate Chemical compound ClC1=CC=C2N(C(=O)OC(C)(C)C)C(S(Cl)(=O)=O)=CC2=C1 ILUBQLROFBISHX-UHFFFAOYSA-N 0.000 claims 1
- GBTWJDAEKNGADB-UHFFFAOYSA-N tert-butyl 5-methyl-3-oxo-2-propylpiperazine-1-carboxylate Chemical compound CCCC1N(C(=O)OC(C)(C)C)CC(C)NC1=O GBTWJDAEKNGADB-UHFFFAOYSA-N 0.000 claims 1
- CSWGIYZSJBBEKY-UHFFFAOYSA-N tert-butyl 6-chloro-2-chlorosulfonylindole-1-carboxylate Chemical compound C1=C(Cl)C=C2N(C(=O)OC(C)(C)C)C(S(Cl)(=O)=O)=CC2=C1 CSWGIYZSJBBEKY-UHFFFAOYSA-N 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 0 CC(*)(C(*)(*)N(C1(C)*)IIC2CC2)N(Cc2nc(*)c(*)[s]2)C1=O Chemical compound CC(*)(C(*)(*)N(C1(C)*)IIC2CC2)N(Cc2nc(*)c(*)[s]2)C1=O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Steroid Compounds (AREA)
- Dental Preparations (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36319699A | 1999-07-28 | 1999-07-28 | |
| US09/363,196 | 1999-07-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2002105011A true RU2002105011A (ru) | 2004-01-20 |
Family
ID=23429232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2002105011/04A RU2002105011A (ru) | 1999-07-28 | 2000-07-26 | Замещенные оксоазагетероциклические производные |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP1208097B1 (enExample) |
| JP (1) | JP4829449B2 (enExample) |
| KR (1) | KR20020087041A (enExample) |
| CN (1) | CN1420882A (enExample) |
| AT (1) | ATE423113T1 (enExample) |
| AU (1) | AU773227B2 (enExample) |
| BG (1) | BG106340A (enExample) |
| BR (1) | BR0013179A (enExample) |
| CA (1) | CA2382755A1 (enExample) |
| CR (1) | CR6563A (enExample) |
| CZ (1) | CZ2002323A3 (enExample) |
| DE (1) | DE60041584D1 (enExample) |
| EE (1) | EE200200045A (enExample) |
| HK (1) | HK1054227A1 (enExample) |
| HR (1) | HRP20020076A2 (enExample) |
| HU (1) | HUP0203375A3 (enExample) |
| IL (2) | IL147495A0 (enExample) |
| MX (1) | MXPA02000888A (enExample) |
| NO (1) | NO20020214L (enExample) |
| PL (1) | PL354998A1 (enExample) |
| RU (1) | RU2002105011A (enExample) |
| SK (1) | SK1182002A3 (enExample) |
| TR (1) | TR200200225T2 (enExample) |
| WO (1) | WO2001007436A2 (enExample) |
| ZA (1) | ZA200200543B (enExample) |
Families Citing this family (95)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4344101A (en) | 2000-03-21 | 2001-10-03 | Smithkline Beecham Corp | Protease inhibitors |
| BR0107282A (pt) * | 2000-09-29 | 2004-07-06 | Cor Therapeutics Inc | Composto, composição farmacêutica e métodos para prevenir ou tratar uma condição em um mamìfero e para inibir a coagulação de amostras biológicas |
| WO2002062423A1 (en) * | 2001-02-02 | 2002-08-15 | Bristol-Myers Squibb Company | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| GB0112836D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
| GB0114005D0 (en) | 2001-06-08 | 2001-08-01 | Glaxo Group Ltd | Chemical compounds |
| GB0114004D0 (en) | 2001-06-08 | 2001-08-01 | Glaxo Group Ltd | Chemical compounds |
| CN1545509A (zh) | 2001-07-02 | 2004-11-10 | 用作趋化因子受体活性调节剂的哌啶衍生物 | |
| GB0120461D0 (en) | 2001-08-22 | 2001-10-17 | Astrazeneca Ab | Novel compounds |
| ATE530184T1 (de) * | 2001-08-24 | 2011-11-15 | Univ Yale | Piperazinon-verbindungen als tumor- und krebsbekämpfende wirkstoffe |
| AU2007229363B2 (en) * | 2001-08-24 | 2009-06-04 | University Of South Florida | Piperazinone Compounds as Anti-Tumor and Anti-Cancer Agents and the Methods of Treatment |
| GB0122503D0 (en) | 2001-09-18 | 2001-11-07 | Astrazeneca Ab | Chemical compounds |
| EP1314733A1 (en) | 2001-11-22 | 2003-05-28 | Aventis Pharma Deutschland GmbH | Indole-2-carboxamides as factor Xa inhibitors |
| US7087604B2 (en) | 2002-03-08 | 2006-08-08 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| SE0200843D0 (sv) | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
| SE0200844D0 (sv) | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
| WO2003087089A1 (en) | 2002-04-16 | 2003-10-23 | Teijin Limited | Piperidine derivatives having ccr3 antagonism |
| CN100360521C (zh) | 2002-04-25 | 2008-01-09 | 帝人株式会社 | 具有ccr3拮抗作用的4,4-二取代的哌啶衍生物 |
| AR040336A1 (es) | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto |
| AU2003272972A1 (en) * | 2002-10-11 | 2004-05-04 | Kowa Co., Ltd. | Method of treatment for cancer |
| US7358268B2 (en) | 2002-12-04 | 2008-04-15 | Sanofi-Aventis Deutschland Gmbh | Imidazole derivatives as factor Xa inhibitors |
| CA2508165C (en) * | 2002-12-06 | 2014-05-06 | Purdue Research Foundation | Pyridines for treating injured mammalian nerve tissue |
| US8729107B2 (en) | 2002-12-06 | 2014-05-20 | Purdue Research Foundation | Pyridines for treating injured mammalian nerve tissue |
| US7429581B2 (en) | 2002-12-23 | 2008-09-30 | Sanofi-Aventis Deutschland Gmbh | Pyrazole-derivatives as factor Xa inhibitors |
| WO2004078715A1 (ja) | 2003-03-07 | 2004-09-16 | Astellas Pharma Inc. | 2,6-ジ置換スチリルを有する含窒素へテロ環誘導体 |
| SE0300957D0 (sv) | 2003-04-01 | 2003-04-01 | Astrazeneca Ab | Chemical compounds |
| US7741341B2 (en) | 2003-05-19 | 2010-06-22 | Sanofi-Aventis Deutschland Gmbh | Benzimidazole-derivatives as factor Xa inhibitors |
| US7223780B2 (en) | 2003-05-19 | 2007-05-29 | Sanofi-Aventis Deutschland Gmbh | Triazole-derivatives as blood clotting enzyme factor Xa inhibitors |
| EP1479675A1 (en) | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | Indazole-derivatives as factor Xa inhibitors |
| US7317027B2 (en) | 2003-05-19 | 2008-01-08 | Sanofi-Aventis Deutschland Gmbh | Azaindole-derivatives as factor Xa inhibitors |
| GB0315111D0 (en) * | 2003-06-27 | 2003-07-30 | Cancer Rec Tech Ltd | Substituted 5-membered ring compounds and their use |
| BRPI0412263B1 (pt) | 2003-07-22 | 2019-10-15 | Arena Pharmaceuticals, Inc. | Derivados de diaril e aril heteroaril uréia, uso e composição farmacêutica contendo os mesmos, bem como processo para preparação da dita composição |
| SE0303180D0 (sv) | 2003-11-26 | 2003-11-26 | Astrazeneca Ab | Novel compounds |
| TWI396686B (zh) | 2004-05-21 | 2013-05-21 | Takeda Pharmaceutical | 環狀醯胺衍生物、以及其製品和用法 |
| US7393865B2 (en) | 2004-06-17 | 2008-07-01 | Neurocrine Biosciences, Inc. | Sleep inducing compounds and methods relating thereto |
| GB0420831D0 (en) | 2004-09-17 | 2004-10-20 | Glaxo Group Ltd | Novel compounds |
| TWI385152B (zh) | 2005-02-17 | 2013-02-11 | Astellas Pharma Inc | Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivatives (I) |
| WO2007008146A1 (en) * | 2005-07-08 | 2007-01-18 | Astrazeneca Ab | Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| WO2007008144A1 (en) * | 2005-07-08 | 2007-01-18 | Astrazeneca Ab | Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| KR20080037655A (ko) | 2005-07-21 | 2008-04-30 | 아스트라제네카 아베 | 신규 피페리딘 유도체 |
| EP1932839A4 (en) * | 2005-09-06 | 2014-09-10 | Shionogi & Co | INDOLECARBOXYLATE ACID DERIVATIVE HAVING ANTAGONIST EFFECT OF THE PGD2 RECEPTOR |
| CA2621261C (en) | 2005-09-22 | 2014-05-20 | Incyte Corporation | Azepine inhibitors of janus kinases |
| JP5114202B2 (ja) | 2005-09-27 | 2013-01-09 | 塩野義製薬株式会社 | Pgd2受容体アンタゴニスト活性を有するスルホンアミド誘導体 |
| JP5473334B2 (ja) | 2005-12-23 | 2014-04-16 | ジーランド ファーマ アクティーゼルスカブ | 修飾リジン模倣化合物 |
| EP1988077A4 (en) | 2006-02-23 | 2009-09-02 | Shionogi & Co | NUCLEIC HETEROCYCLIC DERIVATIVES SUBSTITUTED BY CYCLIC GROUPS |
| JP2009532504A (ja) | 2006-04-06 | 2009-09-10 | グラクソ グループ リミテッド | 抗菌薬 |
| US8017612B2 (en) | 2006-04-18 | 2011-09-13 | Japan Tobacco Inc. | Piperazine compound and use thereof as a HCV polymerase inhibitor |
| WO2007140263A2 (en) * | 2006-05-26 | 2007-12-06 | University Of Louisville Research Foundation, Inc. | Macrophage migration inhibitory factor antagonists and methods of using same |
| EP1882688A1 (en) | 2006-07-25 | 2008-01-30 | EPFL Ecole Polytechnique Fédérale de Lausanne | Labelling of fusion proteins with synthetic probes |
| TWI415845B (zh) | 2006-10-03 | 2013-11-21 | Arena Pharm Inc | 用於治療與5-ht2a血清素受體相關聯病症之作為5-ht2a血清素受體之調節劑的吡唑衍生物 |
| US20080188545A1 (en) | 2006-12-21 | 2008-08-07 | Alimardanov Asaf R | Synthesis of pyrrolidine compounds |
| EP2069324B1 (en) * | 2007-03-20 | 2013-07-31 | Curis, Inc. | Fused amino pyridine as hsp90 inhibitors |
| EP2190844B3 (en) | 2007-08-15 | 2013-07-17 | Arena Pharmaceuticals, Inc. | Imidazo[1,2-a]pyridine derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| TW200944526A (en) | 2008-04-22 | 2009-11-01 | Vitae Pharmaceuticals Inc | Carbamate and urea inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
| US9126946B2 (en) | 2008-10-28 | 2015-09-08 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto |
| CA2741731A1 (en) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Compositions of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related thereto |
| EP2480235A4 (en) | 2009-09-24 | 2013-05-08 | Univ Louisville Res Found | NEW IODO-PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ILLNESSES AND SUFFERING IN CONNECTION WITH THE MACROPHAGE MIGRATION-INHIBITING FACTOR |
| US9155790B2 (en) | 2010-05-20 | 2015-10-13 | University of Lousiville Research Foundation, Inc. | Methods and compositions for modulating ocular damage |
| KR101251282B1 (ko) | 2010-10-18 | 2013-04-10 | 서울대학교산학협력단 | 프로스타글란딘 합성을 억제하는 설폰아미드 유도체 및 이를 포함하는 약학적 조성물 |
| CN102552274B (zh) * | 2010-11-12 | 2013-10-23 | 姚雪彪 | 动点马达蛋白小分子抑制剂在抑制肿瘤细胞增殖中的应用 |
| WO2012071369A2 (en) | 2010-11-24 | 2012-05-31 | The Trustees Of Columbia University In The City Of New York | A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease |
| PL395470A1 (pl) | 2011-06-29 | 2013-01-07 | Adamed Spólka Z Ograniczona Odpowiedzialnoscia | Sulfonamidowe pochodne amin alicyklicznych do leczenia chorób osrodkowego ukladu nerwowego |
| WO2013166037A1 (en) | 2012-05-01 | 2013-11-07 | The Trustees Of Columbia University In The City Of New York | Non-retinoid antagonists for treatment of eye disorders |
| US8669281B1 (en) | 2013-03-14 | 2014-03-11 | Alkermes Pharma Ireland Limited | Prodrugs of fumarates and their use in treating various diseases |
| ES2700541T3 (es) | 2013-03-14 | 2019-02-18 | Univ Columbia | Octahidrociclopentapirroles, su preparación y uso |
| WO2014151936A1 (en) | 2013-03-14 | 2014-09-25 | The Trustees Of Columbia University In The City Of New York | Octahydropyrrolopyrroles, their preparation and use |
| EP2968304B1 (en) | 2013-03-14 | 2018-10-10 | The Trustees of Columbia University in the City of New York | 4-phenylpiperidines, their preparation and use |
| US9938291B2 (en) | 2013-03-14 | 2018-04-10 | The Trustess Of Columbia University In The City Of New York | N-alkyl-2-phenoxyethanamines, their preparation and use |
| CN106794364B (zh) | 2014-04-30 | 2019-12-24 | 哥伦比亚大学董事会 | 取代的4-苯基哌啶及其制备和用途 |
| CA2954212C (en) | 2014-07-31 | 2023-09-19 | Basf Se | Process for preparing pyrazoles |
| CN104557930B (zh) * | 2015-02-14 | 2016-06-01 | 佛山市赛维斯医药科技有限公司 | 一种含二环酰胺结构凝血因子Xa抑制剂及其用途 |
| CN104650082B (zh) * | 2015-02-14 | 2016-06-01 | 佛山市赛维斯医药科技有限公司 | 一类凝血因子Xa抑制剂、制备方法及其用途 |
| CN104650081B (zh) * | 2015-02-14 | 2016-06-01 | 佛山市赛维斯医药科技有限公司 | 凝血因子Xa抑制剂、制备方法及其用途 |
| CN104557927B (zh) * | 2015-02-14 | 2016-06-01 | 佛山市赛维斯医药科技有限公司 | 一种含二环酰胺结构的凝血因子Xa抑制剂及其用途 |
| CN104557928B (zh) * | 2015-02-14 | 2016-08-24 | 佛山市赛维斯医药科技有限公司 | 一种含二环酰胺结构凝血因子Xa抑制剂、其制备方法及其用途 |
| CN104592227B (zh) * | 2015-02-14 | 2016-06-01 | 佛山市赛维斯医药科技有限公司 | 一类含酰胺和卤代苯结构的FXa抑制剂、制备方法及其用途 |
| CN104557929B (zh) * | 2015-02-14 | 2016-06-01 | 佛山市赛维斯医药科技有限公司 | 一类含二环酰胺结构的凝血因子Xa抑制剂及其用途 |
| CN104610257B (zh) * | 2015-02-14 | 2016-06-01 | 佛山市赛维斯医药科技有限公司 | 一类含酰胺结构的FXa抑制剂、制备方法及其用途 |
| CN104610260B (zh) * | 2015-02-14 | 2016-03-30 | 佛山市赛维斯医药科技有限公司 | 一类含酰胺和氮杂环结构的FXa抑制剂、制备方法及其用途 |
| CN104672236B (zh) * | 2015-02-14 | 2016-03-30 | 佛山市赛维斯医药科技有限公司 | 一类含双酰胺基和卤代苯结构的FXa抑制剂及其用途 |
| CN104672235B (zh) * | 2015-02-14 | 2016-02-17 | 佛山市赛维斯医药科技有限公司 | 一类含双酰胺基和烷氧苯基结构的FXa抑制剂及其用途 |
| CN104610259B (zh) * | 2015-02-14 | 2016-06-01 | 佛山市赛维斯医药科技有限公司 | 含酰胺和氮杂环结构的FXa抑制剂、制备方法及其用途 |
| CN104610258B (zh) * | 2015-02-14 | 2016-03-30 | 佛山市赛维斯医药科技有限公司 | 一类含酰胺和甲氧苯结构的FXa抑制剂、制备方法及其用途 |
| JP6833718B2 (ja) | 2015-05-11 | 2021-02-24 | ビーエイエスエフ・ソシエタス・エウロパエアBasf Se | 4−アミノ−ピリダジンを製造するための方法 |
| EP4119141A1 (en) | 2015-06-12 | 2023-01-18 | Axovant Sciences GmbH | Nelotanserin for the prophylaxis and treatment of rem sleep behavior disorder |
| TN2017000508A1 (en) | 2015-06-26 | 2019-04-12 | Takeda Pharmaceuticals Co | 2,3-dihydro-4h-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic m1 receptor |
| EP3322415A4 (en) | 2015-07-15 | 2019-03-13 | Axovant Sciences GmbH | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR FOR PROPHYLAXIS AND TREATMENT OF HALLUCINATIONS RELATED TO A NEUROGENERATIVE DISEASE |
| JP6787913B2 (ja) * | 2015-10-20 | 2020-11-18 | 武田薬品工業株式会社 | 複素環化合物 |
| WO2018082964A1 (en) | 2016-11-04 | 2018-05-11 | Basf Se | Process for the production of pyridazinyl-amides in a one-pot synthesis |
| EP3612527B1 (en) | 2017-04-18 | 2022-07-20 | Takeda Pharmaceutical Company Limited | Heterocyclic compounds useful as modulators of acetylcholine receptors |
| WO2018202865A1 (en) | 2017-05-05 | 2018-11-08 | Zealand Pharma A/S | Gap junction intercellular communication modulators and their use for the treatment of diabetic eye disease |
| CN110054619A (zh) * | 2018-01-18 | 2019-07-26 | 西北农林科技大学 | 新型二酮哌嗪类组蛋白去乙酰化酶抑制剂 |
| CA3096497A1 (en) | 2018-04-10 | 2019-10-17 | Bayer Aktiengesellschaft | Oxadiazoline derivatives |
| CN109991355B (zh) * | 2019-04-12 | 2021-05-11 | 中国烟草总公司郑州烟草研究院 | 一种鉴定动物体内nab代谢产物的方法和评价nab在动物体内暴露风险的方法 |
| WO2022228387A1 (en) * | 2021-04-26 | 2022-11-03 | Fochon Biosciences, Ltd. | Compounds as parp inhibitors |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994018981A1 (en) * | 1993-02-22 | 1994-09-01 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| US5849736A (en) * | 1993-11-24 | 1998-12-15 | The Dupont Merck Pharmaceutical Company | Isoxazoline and isoxazole fibrinogen receptor antagonists |
| US5612353A (en) * | 1995-06-07 | 1997-03-18 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds |
| UA56197C2 (uk) * | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Гетероциклічні похідні |
| NZ500354A (en) * | 1997-04-14 | 2001-11-30 | Cor Therapeutics Inc | Cyclic diaza compounds as selective factor Xa inhibitors for treating thrombotic related disorders |
| WO1999033805A1 (en) * | 1997-12-26 | 1999-07-08 | Mochida Pharmaceutical Co., Ltd. | Aromatic compounds having cyclic amino or salts thereof |
| WO1999037304A1 (en) * | 1998-01-27 | 1999-07-29 | Aventis Pharmaceuticals Products Inc. | SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS |
| CA2317017A1 (en) * | 1998-02-05 | 1999-08-12 | Takeda Chemical Industries, Ltd. | Sulfonamide derivatives, their production and use |
| JP2000204081A (ja) * | 1998-02-05 | 2000-07-25 | Takeda Chem Ind Ltd | スルホンアミド誘導体、その製造法及び用途 |
| JP2003529531A (ja) * | 1998-11-25 | 2003-10-07 | アヴェンティス ファーマシューティカルズ インコーポレイテッド | 置換オキソアザへテロシクリルXa因子阻害剤 |
-
2000
- 2000-07-26 CZ CZ2002323A patent/CZ2002323A3/cs unknown
- 2000-07-26 IL IL14749500A patent/IL147495A0/xx active IP Right Grant
- 2000-07-26 WO PCT/IB2000/001156 patent/WO2001007436A2/en not_active Ceased
- 2000-07-26 EP EP00951781A patent/EP1208097B1/en not_active Expired - Lifetime
- 2000-07-26 SK SK118-2002A patent/SK1182002A3/sk unknown
- 2000-07-26 PL PL00354998A patent/PL354998A1/xx not_active Application Discontinuation
- 2000-07-26 CA CA002382755A patent/CA2382755A1/en not_active Abandoned
- 2000-07-26 MX MXPA02000888A patent/MXPA02000888A/es active IP Right Grant
- 2000-07-26 KR KR1020027001192A patent/KR20020087041A/ko not_active Withdrawn
- 2000-07-26 BR BR0013179-2A patent/BR0013179A/pt not_active IP Right Cessation
- 2000-07-26 HU HU0203375A patent/HUP0203375A3/hu unknown
- 2000-07-26 EE EEP200200045A patent/EE200200045A/xx unknown
- 2000-07-26 CN CN00810877A patent/CN1420882A/zh active Pending
- 2000-07-26 AU AU64628/00A patent/AU773227B2/en not_active Ceased
- 2000-07-26 HK HK03106404.4A patent/HK1054227A1/zh unknown
- 2000-07-26 DE DE60041584T patent/DE60041584D1/de not_active Expired - Lifetime
- 2000-07-26 HR HR20020076A patent/HRP20020076A2/hr not_active Application Discontinuation
- 2000-07-26 AT AT00951781T patent/ATE423113T1/de not_active IP Right Cessation
- 2000-07-26 JP JP2001512520A patent/JP4829449B2/ja not_active Expired - Fee Related
- 2000-07-26 TR TR2002/00225T patent/TR200200225T2/xx unknown
- 2000-07-26 RU RU2002105011/04A patent/RU2002105011A/ru unknown
-
2002
- 2002-01-06 IL IL147495A patent/IL147495A/en not_active IP Right Cessation
- 2002-01-15 NO NO20020214A patent/NO20020214L/no not_active Application Discontinuation
- 2002-01-22 BG BG106340A patent/BG106340A/xx unknown
- 2002-01-22 ZA ZA200200543A patent/ZA200200543B/en unknown
- 2002-01-25 CR CR6563A patent/CR6563A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR200200225T2 (tr) | 2002-06-21 |
| HK1054227A1 (zh) | 2003-11-21 |
| CZ2002323A3 (cs) | 2002-05-15 |
| ZA200200543B (en) | 2003-08-27 |
| SK1182002A3 (en) | 2002-11-06 |
| CR6563A (es) | 2008-11-25 |
| WO2001007436A2 (en) | 2001-02-01 |
| HRP20020076A2 (en) | 2003-12-31 |
| IL147495A (en) | 2007-07-24 |
| BG106340A (en) | 2002-10-31 |
| EP1208097A2 (en) | 2002-05-29 |
| EP1208097B1 (en) | 2009-02-18 |
| EE200200045A (et) | 2003-06-16 |
| BR0013179A (pt) | 2002-04-02 |
| CN1420882A (zh) | 2003-05-28 |
| ATE423113T1 (de) | 2009-03-15 |
| AU773227B2 (en) | 2004-05-20 |
| CA2382755A1 (en) | 2001-02-01 |
| DE60041584D1 (de) | 2009-04-02 |
| JP2003508353A (ja) | 2003-03-04 |
| AU6462800A (en) | 2001-02-13 |
| WO2001007436A3 (en) | 2001-08-23 |
| JP4829449B2 (ja) | 2011-12-07 |
| KR20020087041A (ko) | 2002-11-21 |
| IL147495A0 (en) | 2002-08-14 |
| HUP0203375A2 (hu) | 2002-12-28 |
| MXPA02000888A (es) | 2002-07-30 |
| PL354998A1 (en) | 2004-03-22 |
| NO20020214D0 (no) | 2002-01-15 |
| NO20020214L (no) | 2002-04-02 |
| HUP0203375A3 (en) | 2005-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2002105011A (ru) | Замещенные оксоазагетероциклические производные | |
| RU2405771C2 (ru) | Гетероциклические замещенные фенилметаноны в качестве ингибиторов переносчика глицина 1 | |
| RU2503676C2 (ru) | Пирролопиразиновые ингибиторы киназы | |
| JP6262228B2 (ja) | RORcモジュレーターとしてのアリールスルタム誘導体 | |
| JP2010524984A5 (enExample) | ||
| KR20090090383A (ko) | 이미다조티아졸 유도체 | |
| CN101952286A (zh) | 用于治疗和雄激素受体有关的病症的双环衍生物 | |
| JP2009538896A5 (enExample) | ||
| US20040102450A1 (en) | Substituted oxoazaheterocyclyl compounds | |
| RU2007101544A (ru) | Антагонисты рецепторов высвобождающего гонадотропин гормона | |
| CA2664810A1 (en) | Substituted sulfonamide derivatives | |
| AU2016303558B2 (en) | Dopamine D3 receptor antagonists having a bicyclo moiety | |
| HRP20192323T1 (hr) | Novi derivati dihidrokinolin-2-ona | |
| CA2787291A1 (en) | 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds | |
| EA038143B1 (ru) | ИНГИБИТОРЫ Mcl-1 НА ОСНОВЕ ЗАМЕЩЕННЫХ ИНДОЛОВ | |
| CZ20021390A3 (cs) | Inhibitory tyrosinkinázy | |
| AU2012334074A1 (en) | Inhibitors of phosphodiesterase type 10A | |
| AU2009326141A1 (en) | 2- (piperidin-1-yl) -4-heterocyclyl-thiazole-5-carboxylic acid derivatives against bacterial infections | |
| CN102123990A (zh) | 杂环化合物及其用途 | |
| NZ585221A (en) | Peptide deformylase inhibitors comprising pyrimidinyl and hydrazino moieties and crystalline forms thereof | |
| AU2008263580A1 (en) | Piperidine compounds and uses thereof | |
| KR20240063881A (ko) | 통증, 특히 신경병증성 통증, 및/또는 at2r 및/또는 at2r 매개 신호전달과 연관된 다른 질환 또는 장애의 치료를 위한 화합물 | |
| EP4476211A1 (en) | Acylated heterocyclic quinazoline derivatives as inhibitors of erbb2 | |
| AU2006328196A1 (en) | Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines | |
| TW202239407A (zh) | N-(2-(4-氰基四氫噻唑-3-基)-2-側氧基乙基)-喹啉-4-甲醯胺 |